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 The importance of TNF-TNFR signaling in immunity against M. tuberculosis has 
been established.   
The aims of this study were to characterize the functions of membrane-bound TNF (Tm-
TNF) and soluble TNF (solTNF) and to investigate the role of membrane-bound 
p55TNFR signaling as well as the in vivo significance of TNFR shedding in host immune 
responses during infection with M. tuberculosis H37Rv.  To address this, mice expressing 
only the membrane-bound TNF or membrane-bound p55TNFR were exposed to a low 
dose of M. tuberculosis H37Rv by aerosol inhalation infection.  The results presented in 
this dissertation illustrate that Tm-TNF mice were able to control acute M. tuberculosis 
infection but succumbed to chronic exposure to M. tuberculosis with pneumonia. We 
demonstrate that Tm-TNF mice displayed heightened pulmonary macrophage activation 
reflected by enhanced cell surface expression of MHC-II, CD80 and CD86 as well as 
enlargement of granulomas.  Furthermore, our results show that solTNF has a regulatory 
function that modulates the magnitude of Th1 immune responses during acute and 
chronic stages of the infection.   
 
The evaluation of the functions of Tm-TNF and solTNF in host immune function in the 
presence of an established mycobacteria-specific immune response was carried out using 
a ‗drug-based‘ M. tuberculosis reactivation model.  Here, mice that were challenged with 
a low dose of M. tuberculosis were exposed to INH-RIF treatment for six weeks in 
drinking water, after which therapy was withdrawn and immune responses during 
reactivation were analyzed.  Our results demonstrate that complete absence of TNF 
resulted in host susceptibility to recrudescence tuberculosis in the presence of a 
mycobacteria-specific immune response.  TNF deficient mice were unable to suppress 
bacilli growth and formed diffused granulomas and succumbed early to reappearing 
tuberculosis compared to WT mice.  By contrast, we show that Tm-TNF was sufficient 
for containment of reappearing mycobacterial growth and sustaining immune pressure in 













Lastly, the analysis of host immune responses in mice expressing a non-sheddable 
p55TNFR revealed that persistent p55TNFR cell surface expression does not afford 
better protection to low dose M. tuberculosis infection.  However, we observed a 
transient elevation in the frequency of pulmonary CD11b+/MHC-II+ cells in mice 
expressing a non-sheddable p55TNFR relative to WT mice as well as reduced cell 
surface expression of CD44 on CD4+ T cells.  We also found that pulmonary IL-12p70 
and TNF concentrations were elevated whereas IFNγ levels were reduced in mice 
expressing a non-sheddable p55TNFR relative to WT mice.  Furthermore, data presented 
here describe the in vivo functional significance of p75TNFR shedding.  We demonstrate 
using a double mutant mouse strain that in the absence of p75TNFR, mice expressing a 

















































































        “Since the time people have realized tuberculosis is preventable and since they have learned how to 
avoid the infection, mortality rates caused by tuberculosis have declined in industrialized countries and 




Tuberculosis is still a major global health issue and continues to claim the lives of both 
young and adult humans faster than any other single disease causing organism.  The 
tubercle bacilli have evolved ways to circumvent destruction and defiantly persist in the 
face of hostile innate and adaptive host immune defense mechanisms.  In this regard, in 
some immunocompetent humans, the bacteria induce a lung pathology which ingeniously 
allows for transmission of bacteria by aerosol from one person to another.  Lung 
pathology is initiated at sites of bacterial implantation with attraction and accumulation of 
macrophages and lymphocytes which multiply to form compact granulomas that contain 
the bacteria (Saunders and Cooper, 2000).  In some humans, the granuloma structure can 
result in cavities with central caseous necrosis (Fayyazi et al., 2000).  The key feature of 
granuloma formation is the development of fibrosis within the granuloma and the 
surrounding lung parenchyma giving rise to the tubercle nodules.  Depending on the 
metabolic status of the bacteria, the disease advances as a necrotizing pneumonic process 















The pathogen identified to be the causative agent of tuberculosis is Mycobacterium 
tuberculosis (M. tuberculosis) was discovered in 1882 by Robert Kock.  Classical 
characteristics of M. tuberculosis include that it is a gram-positive, slow growing, 
facultative intracellular pathogen (Manganelli et al., 1999).  It shares with other members 
of the Mycobacterium genus a unique waxy cell wall of which the majority of the 
constituents are mycolic acids which make up more than 50% of the bacteria‘s dry weight 
(Brennan and Nikaido, 1995).  This allows the bacteria to retain basic dyes in the 
presence of acid alcohols, hence their acid fastness (Allen, 1992). 
 
Another characteristic feature of M. tuberculosis is the ability to remain latent in infected 
hosts.  Of those who are infected, 90% do not develop active disease (WHO report, 
2009).  These individuals represent a large reservoir of M. tuberculosis with the potential 
for reactivation and driving the epidemic.  Furthermore, factors such as the increase of 
the world‘s poor, the menace of HIV/AIDS, emigration due to political or economic 
instabilities, and global interdependency are set to increase tuberculosis cases globally for 
the foreseeable future.  Epidemiologists‘ estimate that 2 billion of the world‘s population 
is infected with M. tuberculosis, and 9.27 million new tuberculosis cases occurred in 
2007 alone (WHO report, 2009).  According to the global distribution pattern, the 
majority of high tuberculosis incidences (Fig. 1) are restricted to developing countries 
and this phenomenon is associated with high incidence of human immunodeficiency 

























Figure 1.  The global distribution pattern of estimated tuberculosis incidences in 2007 shows that the 























Figure 2.  Of the 15 countries with the highest estimated tuberculosis incidence rates per capita in 2007, 
13 are in Africa.  (Grey bars indicate tuberculosis in all ages and the blue bars indicate the corresponding 


















Most of what is known about the in vivo host response to M. tuberculosis infection comes from the use of 
animal models of the disease, mostly mice.  This animal host has also proved valuable in investigating 
aspects of host-pathogen relationships such as the molecular basis of M. tuberculosis virulence, a feature 
that can be investigated only in terms of environmental changes induced in the host.  The availability of 
inbred strains that differ from one another with respect to the degree of resistance to tuberculosis, the 
availability of genetically altered mutant mouse strains and the fact that mice are much less expensive to 
purchase and to maintain, make them attractive tuberculosis animal models compared with other host 
species.   
   
Pattern of infection in mice 
The growth of M. tuberculosis in mice is well characterised.  Mouse strains resistant to 
challenge with M. tuberculosis are able to control lung infection.  In resistant C57BL/6 
and BALB/c strains (Medina and North, 1996; North et al., 1999; North and Medina, 
1998), infection via the respiratory route with 100 or fewer M. tuberculosis bacilli results 
in exponential bacterial replication in the lungs reaching up to 6.5 logs by day 20 post-
infection.  The onset of mycobacteria specific adaptive immunity results in inhibition of 
further bacterial growth which give rise to an approximate stationary phase of the 
infection that persists from day 20 until the mice succumb to infection by day 250.  Smith 
and colleagues (Schell et al., 1974) first described the description of this pattern of lung 
infection in mice more than 30 years ago.  The infection is however not confined to the 
lungs but is disseminated to other organs via lymph and blood (Chackerian et al., 2002).  
The bacilli can be recovered from livers and spleens by day 15 post-infection and bacilli 
growth progresses until day 20 and, when systemic immunity is expressed, further 












2001).  McCune and Tompsett (1956) described the events of mice infected via the 
intravenous route nearly 50 years ago and revealed that most of the bacilli implants in 
liver (95%) and spleen (about 4%) and 0.1% implants in the lung after mice are 
inoculated via the iv route.  Interestingly, in the lung, the tubercle bacilli replicate 
progressively for 20 days compared to 10 days in the liver and spleen before station 
phase of the infection is established (Medina and North, 1996). 
 
Progression of infection in M. tuberculosis susceptible mouse strains is different.  
Infection of susceptible strains such as DBA/2, C3H, CBA, 129Sv (Medina and North, 
1996; Medina and North, 1998; Mitsos et al., 2003) via the respiratory route or the 
intravenous route result in rapid bacterial growth in the lungs for the first 20 days as in 
resistant mouse strains but the established chronic phase in these mice is unstable as a 
result they succumb to infection with a mean survival time of 100 - 150 days.  In 
addition, studies by Gruppo et al., 2002, revealed that susceptibility of these mouse 
strains was associated with reduced and delayed trafficking of T lymphocytes in the lung 
which correlated with a poor upregulation of adhesion and integrin molecules necessary 

















Immunity to tuberculosis 
 
That immunity to M. tuberculosis and other facultative intracellular bacteria is cell mediated was proposed 
by Mackaness in the 1960s.  He saw lymphocytes as the cells that specifically mediate immunity and the 
macrophages as the cells that indiscriminately express it (Mackaness, 1969).  Based on his analyses, before 
macrophages can express immunity, they need to be activated into assassin mode, and it is the function of 
antigen-specific lymphocytes that give macrophages the licence to kill the invading bacteria.  It was later 
established in the 1970s that antigen-specific T cells achieved this by secreting humoral factors, known 




There is extensive evidence to support a central role for a type 1 (Th1) immune response 
in mice and humans for the generation of a protective immune response against M. 
tuberculosis infection.  Many components of the immune system appear to be necessary 
for induction of a protective response, which include T cells, cytokines such as gamma 
interferon (IFNγ) and tumor necrosis factor (TNF), and macrophage activation.  The 
macrophage activating and Th1 polarizing phenotype is favoured over an antibody-
dominated Th2 response by the local release of interleukin-12 (IL-12) from infected cells 
(Ladel et al., 1997).  Studies from mouse models and evidence obtained from individuals 
with susceptibility to disseminated infection with M. bovis BCG and other weakly 
pathogenic mycobacteria identifies the IL-12-IFNγ loop to be crucial for protection 
against infection (Altare et al., 1998; Cooper et al., 1993; Cooper et al., 1997; Flynn et 















CD4+ T cells 
Within the infected macrophage, M. tuberculosis resides primarily in a phagosome 
resulting in MHC Class II presentation of mycobacterial antigens to CD4+ T cells.  
Several studies have shown that the primary effector function of CD4+ T cells in 
protection against tuberculosis is the production of IFNγ that is essential for activating 
macrophages (Cooper et al., 1993; Flynn et al., 1993; Orme et al., 1993).  Mice deficient 
in CD4+ T cells had diminished ability to control infection indicating the importance of 
this subset in protective immunity against M. tuberculosis (Caruso et al., 1999; Tascon et 
al., 1998).  Furthermore, adoptive transfer of CD4+ T cells enhanced protection against 
tuberculosis in mice (Orme et al., 1987).  Moreover, in human hosts, HIV+PPD+ 
individuals revealed that loss of CD4+ T cells greatly enhanced the susceptibility to acute 
and reactivation tuberculosis (Selwyn et al., 1989).  Other possible roles of CD4+ T cells 
have been suggested, these include mediating apoptosis, which is thought to play a role in 
M. tuberculosis infection, conditioning of antigen-presenting cells, providing help for B 
cells and CD8+ T cells, and production of other relevant cytokines (Balcewicz-Sablinska 
et al., 1998; Keane et al., 1997). 
 
CD8+ T cells 
CD8+ T cells recognize antigens derived from the cytoplasm of infected cells presented 
by the MHC Class I molecules.  Although M. tuberculosis resides predominantly inside 
vacuoles of infected cells, reports have suggested that the tubercle bacilli may gain access 
to the cytoplasm via pore formation in the vacuole membrane (Teitelbaum et al., 1999).  












tuberculosis (Flynn et al., 1992; Orme et al., 1987; Rolph et al., 2001; van Pinxteren et 
al., 2000).  Although mycobacteria specific cytotoxic CD8+ T cells have not been isolated 
from mice or humans, a CD8+ T cell clone isolated from mice vaccinated with 
mammalian cells expressing mycobacterial 65kDa antigen, was able to transfer protection 
and was cytotoxic against infected macrophages in vitro (Silva et al., 1994).  
 
CD8+ T cells also recognise antigens presented by Class 1b molecules.  These are non-
polymorphic and include the CD1 molecules (Porcelli and Modlin, 1999) as well H2-M3 
(Chiu et al., 1999) and present mycobacterial lipids and glycolipids vastly expanding the 
repertoire of possible antigen pool.  
 
Effector functions of CD8+ T cells include amongst others, production of IFNγ and TNF 
(Caruso et al., 1999; Scanga et al., 2000) as well as lysis of infected cells.  The lysis of 
target cells was shown to be mediated by production of perforin and granzymes or via the 
Fas/FasL pathway (Stenger et al., 1998).  Using CD8 deficient mice, CD95 and CD95L 
deficient mice, Turner and colleagues (2001) showed that CD8 T cell mediated immunity 
was not required during early stages of the infection, but was important during chronic M. 
tuberculosis infection.  Moreover, in the same study, the authors also revealed that 
perforin gene-disrupted mice were not more susceptible to chronic infection that WT 
control mice.  In humans, CD8+ T cells also produce granulysin, which was shown to be 
directly toxic to M. tuberculosis representing another effector mechanism by which CD8+ 
T cells contribute to the killing of the tubercle bacilli within cells (Stenger et al., 1998; 












γδ T cells 
Non-protein components of mycobacteria such as isopentenyl pyrophosphate and prenyl 
pyrophosphate were shown to activate a further set of T cells carrying antigen-specific 
receptor made up of the γ and δ chains (Constant et al., 1994).  Even though the role of γδ 
T cells in immunity has not been fully described, disruption of T cell receptor (TCR) δ 
genes proved to have detrimental effects in mice challenged with M. tuberculosis 
(D'Souza et al., 1997).  Here, IFNγ production and lysis of target cells also appeared to be 
contributory effectors in tuberculosis immunity afforded by γδ T cells (Tsukaguchi et al., 
1995).  
 
Macrophages as the effectors of Th1 immunity 
The macrophage is central to the control of M. tuberculosis infection.  Tubercle bacilli 
multiply in resting macrophages, but activation of these infected macrophages with IFNγ 
resulted in induction of a mycobacteriostatic or mycobactericidal state in vitro (Flesch 
and Kaufmann, 1987).  Tumor necrosis factor and IFNγ were shown to collaborate to 
induce production of nitric oxide (NO) and related reactive nitrogen intermediates 
(RNIs), which represent one of the antimicrobial defence mechanism launched by 
activated macrophages (Ding et al., 1988).  NO is generated from L-arginine via the 
enzymatic action of the inducible isoform of nitric oxide synthase (NOS2) (Ding et al., 
1988) and its importance in protective immunity was confirmed in studies where mice 
deficient of NOS2 activity were shown to be susceptible to M. tuberculosis infection 
(Chan et al., 1995; Flynn et al., 1998; MacMicking et al., 1997; Scanga et al., 2001).  The 












reports of NOS2 induction and/or RNI production by human macrophages (Bonecini-
Almeida et al., 1998; Nicholson et al., 1996; Rockett et al., 1998).  In addition, 
production of reactive oxygen, which is generated by the transfer of an electron from 
NADPH to molecular oxygen by the action of NADPH-oxidase is required for 
antimicrobial defence.  Studies with mice incapable of expressing NADPH-oxidase were 
found to be susceptible to M. tuberculosis compared to WT mice (Cooper et al., 2000). 
 
Why does immunity not achieve sterility to the infection? 
 
Deficiency in Th1 immunity versus macrophage function:  
A puzzling question in tuberculosis research is explaining why immunity to M. 
tuberculosis is not sufficient to resolve lung infection in mice, guinea pigs, rabbits, or 
susceptible humans to stop the development of disease.  Macrophages as the cells that 
express immunity directed by mycobacteria-specific T cells have been implicated as one 
the reasons for failure of mice and other hosts to resolve the infection.  This might be due 
to innate defects that prevent macrophages from expressing anti-mycobacterial functions 
or, alternatively, to an inability of the host to mount a sufficient Th1 macrophage 
activating response.  Also not known is whether macrophages would acquire improved 
mycobactericidal abilities that would resolve the infection if the number of mycobacteria-
specific Th1 cells were to be substantially increased.  
Other researchers have suggested that a Th1 immune response is not capable of resolving 
the infection because of the immunoregulating effects of Th2 immunity (Lin et al., 1996).  












demonstrate an improved ability to resolve M. tuberculosis infection in comparison to 
WT mice (Hernandez-Pando et al., 1996).  Likewise, the anti-inflammatory cytokine IL-
10, produced by macrophages and T cells during the M. tuberculosis infection and known 
to posses macrophage deactivating properties including downmodulation of IL-12 which 
in turn decreases IFNγ production by T cells, was found not be responsible for failure of 
immunity to resolve infection.  This was demonstrated in IL-10 gene-deficient mice, 
which displayed similar M. tuberculosis growth kinetics to WT control mice (North, 
1998).  Another potent immunoregulator, transforming growth factor (TGF)-β, has been 
implicated in suppression of T cell responses in tuberculosis patients (Hirsch et al., 1997) 
and was shown to participate in macrophage deactivation by inhibiting IFNγ-induced 
NOS2 production (Ding et al., 1990).  TGF-β can be detected in granulomas of 
tuberculosis patients and its transcription was enhanced in human monocytes after 
stimulation with M. tuberculosis, PPD (Toossi et al., 1995), or lipoarabinomannan (Dahl 
et al., 1996).  Although the in vivo role of TGF-β in resistance or susceptibility in 
tuberculosis has not been directly tested, neutralization of TGF-β activity resulted in 
enhanced bacterial control in monocytes infected with M. tuberculosis (Toossi et al., 
1995). 
 
Breaking the resolve:  Immune evasion 
The ability of M. tuberculosis to evade the immune response should be considered a key 
factor influencing resolution of infection.  The ability of M. tuberculosis bacilli to persist 
within macrophages, whose primary function is to kill invading microbes suggest the 












anti-mycobacterial mechanisms of activated macrophages (Chan et al., 1995; 
MacMicking et al., 1997).  Studies by Chen and colleagues (1998), showed that M. 
tuberculosis ahpC, which encodes the peroxiredoxin alkyl hydroperoxide reductase 
subunit C (AhpC), protects Salmonella typhimurium and mammalian cells from RNI 
toxic effects.  AhpC was shown to catalytically catabolize peroxynitrite anion (ONOO-) 
which is a potent oxidant formed by the reaction between NO and superoxide oxide (O-) 
produced by activated macrophages (Bryk et al., 2000).  In addition, M. tuberculosis 
AhpC peroxiredoxin in concert with mycobacterial dihydrolipoamide dehydrogenase 
(Lpd), dihydrolipoamide succinyltransferase (SucB), and thioredoxin-like AhpD, were 
reported to form an antioxidant complex with nicotinamide adenine dinucleotide 
(reduced)-dependent peroxidase and peroxynitrite reductase activity (Bryk et al., 2002). 
 
Another means by which M. tuberculosis evades the immune system is achieved by 
interfering with the tethering and fusion machinery that is involved in the maturation of 
phagosomes into phagolysosomes (Desjardirns M, 1995; Viera OV, 2002).  In addition, it 
is reported that once inside the phagosomes, bacilli are able to maintain an 
intraphagosomal pH environment that is suitable for its survival by way of excluding 
vacuolar H+ ATPases (Sturgill-Koszycki S, 1994). 
 
In other studies, M. tuberculosis was found to inhibit MHC II antigen processing and 
presentation.  CD4+ T cells‘ recognition of infected macrophages depend on MCH II 
presentation of mycobacterial antigens by macrophages (Mazzaccaro et al., 1996).  












tuberculosis infection through intracellular sequestration of MHC II molecules (Hmama 
et al., 1998), decreasing the expression of the class II transactivator (CIIT) 
(Wojciechowski et al., 1999), or by inhibiting IFNγ signalling pathways in the 
macrophages (Ting et al., 1999).  In addition, studies addressing antigen processing in the 
phagosomes showed that MHC II-mycobacterial peptide complexes are formed in the 
phagosomes.  It was observed that phagosomes containing viable M. tuberculosis had 
fewer MHC II-mycobacteria peptide complexes compared to phagosomes containing 
heat-killed M. tuberculosis, suggesting that live bacilli inhibited the processing of 
antigens (Ramachandra et al., 2001). 
 
In summary, there is extensive evidence to support a central role for a type 1 (Th1) 
immune response in mice and humans for the generation of a protective immune response 
against M. tuberculosis infection.  Many components of the immune system appear to be 
necessary for induction of a protective response and these include T cells, cytokines such 
as IFNγ and TNF, and macrophage activation.  A deeper understanding of the underlying 
molecular mechanisms in the complex network of these immune responses will help in 






















































Tumor necrosis factor (TNF, TNFα) was discovered due its tumor necrotizing activities 
in mice (Carswell et al., 1975).  Independently, a molecule termed ‗cachectin‘ associated 
with wasting and hypertriglyceridemic state in rabbits infected with T. brucei was 
investigated (Kawakami and Cerami, 1981; Pekala et al., 1983).  In the mid 1980s, the 
amino acid sequence of human TNF was determined and it was found to be homologous 
to mouse cachectin thus establishing the identity of TNF and cachectin (Aggarwal et al., 
1985; Nedwin et al., 1985).  Although initially identified as a product of activated 
macrophages (Carswell et al., 1975), TNF is now known to be produced by many cell 
types including T cells (Steffen et al., 1988), B cells (Sung et al., 1988), mast cells 
(Gordon and Galli, 1990), keratinocytes (Kock et al., 1990), astrocytes and microglial 
cells (Sawada et al., 1989), smooth muscle cells (Warner and Libby, 1989), intestinal 
paneth cells (Keshav et al., 1990), and mesengial cells (Baud et al., 1989). 
 
TNF and its receptors 
TNF is a member of the TNF superfamily (TNFSF), which is a class of structurally 
related cytokines that are involved in diverse immunological and developmental 
pathways (Table 1) (Bodmer et al., 2002; Ware et al., 2003).  TNF is initially synthesized 
as a 26kDa non-glycosylated type II transmembrane molecule (Tm-TNF) that can be 
released from the cell surface by the metalloprotease TNF-α-converting enzyme (TACE) 
to generate a 17kDa portion, and subsequent to homotrimerisation, a 51kDa soluble TNF 
(solTNF) molecule is formed (Black et al., 1997; Kriegler et al., 1988; Mueller et al., 












TNF functions is mediated by two TNF receptors: p55TNFR (TNFRSF1A, CD120a, 
TNFR1) and p75TNFR (TNFRSF1B, CD120b, TNFR2) with Tm-TNF preferentially 
signaling through p75TNFR and solTNF binding strongly to p55TNFR (Grell et al., 
1998).  In addition, in its homotrimeric form, LTα (a ligand within the TNFSF) also 
interacts with TNFRs to elicit biological responses similar to that of TNF (Smith et al., 





























TNFRs are type I transmembrane glycoproteins sharing 28% homology in their 
extracellular domains but have distinct cytoplasmic domains and need to recruit cytosolic 
intermediate proteins in order to transduce signals (Fig. 3).  Both these receptors are 
regulated differently and display distinct expression patterns, with p55TNFR widely 
expressed in many cell types and, p75TNFR expressed mainly in hematopoietic cells 





























Figure 3.  TNF (Tm-TNF and SolTNF) signaling pathway through TNFR1 and TNFR2.  TNF 
interaction with TNFR1 activates the cell survival and proliferation pathways as well as pathways that lead 
to apoptosis.  TNFR2 play an important role in the regulation of apoptosis through TNFR1 although the 
molecular mechanisms involved in the regulation of cell survival-cell death remain obscure.  
Abbreviations: cIAP 1/2, cytoplasmic inhibitor of apoptosis 1/2; JNK, cJun N-terminal kinase; p38MAPK, 
p38 mitogen-activated protein kinase; RIP, receptor interacting protein; ROS, reactive oxygen species; 
TRADD, TNF receptor-associated death domain; TRAF1/2/6, TNF receptor-associated factor 1/2/6.  
















TNF-TNFR signaling in health and disease 
Earlier studies described two opposing functions of TNF, one with seemingly deleterious 
effect observed when TNF is produced in excess amounts leading to lethal septic shock 
and the other more beneficial effect resulting in protective immunity against invading 
intracellular pathogens (Bean et al., 1999; Flynn et al., 1995; Pfeffer et al., 1993; Rothe et 
al., 1993a; Tracey et al., 1987).  With the generation of gene knockout mice, a 
constellation of TNF-TNFR functions have been described.  These include a role in 
organization of secondary lymphoid tissues.  Pasparakis et al., (1997), demonstrated that 
TNF or p55TNFR gene deficient mice have partial defects in B-cell follicles formation, 
follicular dendritic cell and germinal centers, but display nearly normal humoral immune 
responses.  However, a more pronounced phenotype was observed in mice lacking LT 
which displayed a complete absence of lymphoid tissues such as lymph nodes and 
Peyer‘s patches (Fu and Chaplin, 1999). 
 
Cancer  
With regards to the observed anti-tumor activity of TNF (Carswell et al., 1975), a role in 
immune surveillance against malignancy has been proposed.  However, in the absence of 
TNF, mice did not develop spontaneous tumors nor did they exhibit accelerated tumor 
growth when transplanted in the peritoneum (Smyth et al., 1998).  Surprisingly, in 
another study, mice lacking TNF were protected against skin tumors (Moore et al., 1999).  
It has been suggested that TNF anti-tumor activities in certain mouse models is possible 
when immunostimulation is limited and the inflammatory response at the sites of tumor is 












transgenic mice developed spontaneous pancreatic tumors (Calzascia et al., 2007); 
however, this was not observed in studies conducted by Kuprash et al., (2008) in mice 
lacking p55TNFR.  The relevance of these conflicting observations is yet to be 
established in humans. 
 
Inflammatory disorders 
TNF production is tightly regulated by a variety of mechanisms (Biragyn and 
Nedospasov, 1995; Black et al., 1997; Han et al., 1990; Shakhov et al., 1990; Xanthoulea 
et al., 2004).  Studies have shown that overexpression of TNF leads to pathologic 
consequences as observed in transgenic mice expressing a human TNF with a modified 
3‘-unstralated region of TNF mRNA where these mice developed polyarthritis with 
synovial inflammation, cartilage damage, and bone destruction (Keffer et al., 1991).  In 
another study, overexpression of TNF in addition to promoting arthritis also induced 
wasting as well as multiple organ necroses (Probert et al., 1995).  Other phenotypes such 
as Crohn‘s-like inflammatory bowel disease (IBD) (Kontoyiannis et al., 1999) and 
psoriasis (Schottelius et al., 2004) have been reported to be associated with deregulated 
TNF levels.  Furthermore, the effect of TNF antagonists in disease pathogenesis of 
rheumatoid arthritis (Lipsky et al., 2000; Setoguchi et al., 2006), Crohn‘s disease (Present 
et al., 1999) corroborates the functional relevance of TNF and TNFR expression observed 
in mouse studies.  However, considering that TNF is critical for immune regulation and 
in host defense, a deeper understanding of the therapeutic mechanisms and efficacy of 












demonstrated that anti-TNF therapy in rheumatoid arthritis inhibits memory B cells by 
affecting lymphoid germinal centers and follicular dendritic cell networks. 
 
TNF-TNFR signaling in host immunity against mycobacterial infections 
TNF gene deletion (Bean et al., 1999; Kaneko et al., 1999; Roach et al., 2002), p55TNFR 
gene deletion (Flynn et al., 1995), and TNF neutralization studies (Eriks and Emerson, 
1997; Kindler et al., 1989) demonstrated that TNF has a critical function in protective 
immunity against mycobacterial infections.  In the absence of TNF, mice challenged with 
either avirulent M. bovis (Jacobs et al., 2000b) or virulent M. tuberculosis (Bean et al., 
1999) were shown to succumb to infection more rapidly compared to the wild type 
control mice.  However, TNF deficient mice displayed survival rates that were 
comparable to wild type control mice after challenge with a non-pathogenic M. 
smegmatis strain (Roach et al., 2002). 
 
Granuloma structure formation is imperative to host resistance against invading 
mycobacteria, and their absence usually coincides with mycobacterial dissemination and 
lethality (Bean et al., 1999; Kindler et al., 1989).  TNF has been implicated in 
inflammatory processes that lead to protective granuloma structure formation.  The 
mRNA expression levels of chemokines that facilitate cellular recruitment and formation 
of granuloma were observed to be delayed in the livers of TNF deficient mice relative to 
wild type control mice after challenge with M. smegmatis (Roach et al., 2002).  However, 
this early delay in chemokine mRNA expression was not observed in the lungs of TNF 












studies by Kindler et al., (1989), demonstrated that treatment of mice with anti-TNF 
monoclonal antibody interferes with granuloma structure formation if administered after 
one to two weeks post-infection with M. bovis resulting in fewer and smaller granulomas.  
Additionally, fully developed granulomas disintegrated after treatment of mice with anti-
TNF monoclonal antibody.  This was further corroborated by studies by Mohan et al., 
(2001), illustrating the importance of continuous TNF expression in protective granuloma 
structure maintenance. 
 
An immunoregulatory TNF function has been described in mycobacterial infections.  
Studies by Roach et al., (2002), demonstrated enhanced Th1 immune responses 
associated with increased CD4+ T cell numbers and increased IFNγ production in TNF 
deficient mice compared to wild type control mice after infection with M. smegmatis.  
This is line with Zganiacz et al., (2004), who demonstrated that TNF has a negative 
regulatory effect of Th1 immune responses.  In their studies the authors illustrated that 
relative to wild type control mice; TNF deficient mice displayed excess IL-12 and IFNγ 
production, enhanced antigen specific CD4+ and CD8+ T cell responses, and tissue 
destruction after M. tuberculosis challenge. 
 
In summary, the multiple TNF effects described here are an indication of complex TNF 
biology.  The continued generation of more specific transgenic mice, and newer 
technologies addressing the roles and contributions of cell specific or tissue specific TNF 
production would allow for more detailed studies in understanding the involvement of 














































Wild type (WT) mice were used as controls, TNF-/- mice (deficient in TNF) (Marino et 
al., 1997), Tm-TNF mice: express only the membrane–bound TNF; the endogenous TNF 
allele was replaced by knocking-in the ∆1-9,K11E TNF allele which ensures complete 
loss of TACE mediated cleavage (Ruuls et al., 2001), p55∆NS mice: express only the 
membrane-bound p55TNFR  (Xanthoulea et al., 2004), p75-/- mice (deficient in 
p75TNFR) (Erickson et al., 1994), and p55∆NS-p75-/- mice (obtained by mating p55∆NS 
mice and p75-/- mice) were bred, maintained and housed in IVCs under specific pathogen 
free conditions in the animal unit facility of University of Cape Town (Cape Town, South 
Africa).  For all the experiments, age matched mice on a C57BL/6 background were 
used.  All the experiments and protocols performed were in accordance with the 
guidelines of Research Ethics Committee of the University Of Cape Town, South Africa.   
 
Bacteria and infections 
M. tuberculosis H37Rv was obtained from Trudeau Mycobacterial Culture Collection 
and grown in Middlebrook 7H9 broth (Becton, Dickinson and Company, Le Pont de 
Claix, France) supplemented with 10% Middlebrook OADC enrichment medium (Life 
Technologies, Gaitherburg, MD), 0.5% glycerol and 0.05% Tween 80 at 37°C until log 
phase.  Prior to usage, mycobacterial aliquots were passed 30x through a 29.5 G needle to 
minimize bacterial clumping.  Pulmonary infection with 100 live M. tuberculosis H37Rv 
bacteria was performed using a Glas-Col Inhalation Exposure System, Model A4224.  
Inoculum size was confirmed 24 h post-infection by determining the bacterial numbers in 












For the M. tuberculosis reactivation model (Fig. 1), groups of mice were infected by 
aerosol inhalation with 100 viable M. tuberculosis H37Rv bacilli.  The infection was 
allowed to progress for 21 days before commencement of treatment with 25 mg/Kg INH 
and 25mg/Kg of RIF (Botha and Ryffel, 2003) (Sigma, St. Louis, USA) in drinking water 
for 6 weeks to reduce bacilli numbers to at least less than 100 CFUs in the lungs after 














Figure 1.  Graphic presentation of drug-based M. tuberculosis reactivation mouse model.  Lines A and B 
depicts the ‗Low dose infection model‘; A: Preimmune phase, short bacterial replication period post-
infection with low dose M. tuberculosis; B: Host immunity is solely responsible for controlling the M. 
tuberculosis growth and establishment of a chronic infection.  Lines A, D and E show the ‗Drug based 
model‘; D: Reduction of bacterial numbers to very low levels using a short course regimen of 































Colony enumeration assay 
Bacterial burdens in the lungs, livers and spleens of infected mice were determined at 
specific time points after infection with M. tuberculosis H37Rv.  Organs were weighed 
and homogenized in 0.04% Tween 80 saline.  Tenfold serial dilution of organ 
homogenates were plated in duplicates on Middlebrook 7H10 (Becton, Dickinson and 
Company) agar plates containing 10% OADC (Life Technologies, Gaitherburg, MD) and 
incubated at 37°C for 19-21 days.  Colonies on plates were enumerated and bacterial 
burdens determined. 
 
Microscopic investigation of the lungs 
Mice were euthanized by carbon dioxide inhalation at specific time points.  Organs were 
weighed and fixed in 10% formalin and paraffin-embedded (Appendix).  Two to 3 µm 
sections were stained with haematoxylin and eosin (H&E) and a modified Ziehl-Neelson 
(ZN) method (Appendix).  For immunostaining, formalin-fixed paraffin-embedded 
sections were deparaffinised and rehydrated then stained with rabbit anti-mouse specific 
inducible nitric oxide synthase (iNOS) as described (Garcia et al., 2000).  Sections were 
then washed in PBS (Appendix) and incubated for 30 min at room temperature with 
biotinylated secondary antibody then subsequently incubated with avidin-biotin 
complexes (Vector Laboratories, CA, USA) for 30 min, washed and incubated with DAB 















Lung homogenate preparations 
Whole lungs were removed from infected mice at specific time points and were 
homogenized in 1 ml 0.04% Tween 80 saline containing protease inhibitor (Sigma) 
(Appendix) and the supernatants were collected after low-speed centrifugation, aliquoted 
and frozen at -80°C.  
 
Cytokine ELISA 
Supernatants from organ homogenates or from cultured cells were harvested and assayed 
for cytokine concentration using commercially available ELISA reagents for TNF, IFNγ, 
IL-10, IL-12p40, IL-12p70, p55TNFR and p75TNFR (R&D Systems, Germany and BD 
PharMingen, San Diego), according to the manufactures instructions (See Appendix, 
brief description). 
 
Lung single cell preparation 
Lungs of infected mice were perfused by injecting 5 ml cold PBS (Appendix) containing 
20 U/ml heparin (Bodene (PTY) Limited, RSA) in the right ventricle of the heart.  Lungs 
were then removed, sectioned and incubated in PBS (Appendix) containing 50 U/ml 
collagenase 1 (Worthington Biomedical Corporation, Lakewood, NJ) and 13 µg/ml 
DNAse 1 (Boeringer-Mannheim, Germany) at 37°C for 90 min with rotation.  For single 
cell suspension, lung tissue was passed through a 70 µm nylon cell strainer (Beckton and 
Dickinson) washed 2x with PBS (Appendix) and viable cell numbers were determined by 













Flow cytometry and cell surface markers 
Isolated lung cells were counted and incubated for 20 min on ice with 25 µl FACS 
blocking buffer (Appendix), washed 2x with 475 µl ice-cold FACS buffer (Appendix) 
and centrifuged at 4°C for 5 min at 514 RCF.  Cells were then incubated for 20 min on 
ice with either 25 µl of specific antibody at 2 µg/ml or anti-IgG control antibody at 2 
µg/ml in the dark (See Appendix, antibodies used).  Following this, cells were washed 2x 
with 475 µl ice-cold  FACS buffer (Appendix) to remove excess antibodies then 
centrifuged at 4°C for 5 min at 514 RCF, the cell pellet was then resuspended in 200 µl 
FACS fixation buffer (Appendix).  Samples were acquired using FACSCalibur (Beckton 
and Dickinson) and analysed using FlowJo 7.5 software (Tree star, Ashland, OR, USA).    
 
Preparation of elicited peritoneal macrophages 
Mice were injected with 3% thioglycollate (Difco, St. Louis, USA).  Five days later, 
peritoneal exudate cells were isolated from the peritoneal cavity by washing with ice-cold 
RPMI (Sigma, Germany) supplemented with 10% FCS (Gibco, Invitrogen Corporation, 
Germany).  Cells were cultured overnight at 37°C and 5% CO2 incubator.  Adherent 
monolayer cells were used as peritoneal macrophages and were cultured at 5x105 cells/ml 
in RPMI supplemented with 10% FCS and stimulated for 20 min with either 100 ng/ml 
















Preparation of primary macrophage cultures 
Bone marrow cells were isolated from femurs of 6 to 8 weeks old naive mice and 
cultivated on 90 mm Sterilin plates (Bibby Sterilin, UK) at 2x106  cells/ml for 7 days in 
RPMI (Sigma, Germany) supplemented with 2 mM L-glutamine (Gibco, Invitrogen 
Corporation, Germany), 0.2 µM 2-ME (Sigma, St. Louis, USA), 20% horse serum 
(Gibco, Invitrogen Corporation, Germany) and 30% L929 cell-conditioned medium at 
37°C and 5% CO2.  Adherent cells were harvested by adding PBS (Appendix) containing 
0.02% EDTA (Merck Chemicals, Gauteng, RSA) and 4 mg/ml lidocain hydrochloride 
monohydrate (Sigma-Aldrich, L5647-15G) and incubated for 5 min at 37°C, cells were 
then washed with PBS (Appendix) and centrifuged at 405 RCF.  Following this, cells 
were resuspended in RPMI (Sigma, Germany) containing 10% FCS (Gibco, Invitrogen 
Corporation, Germany), 100 U/ml penicillin (Gibco, Invitrogen Corporation, Germany) 
and 100 ng/ml streptomycin (Gibco, Invitrogen Corporation, Germany) and plated at 
5x105 cells/ml in 96 well tissue culture plates (Nunclon, Denmark) and incubated for 24 h 
at 37°C and 5% CO2 to allow for cell adherence.  Cells were then stimulated with either 
100 ng/ml LPS (E. coli, serotype O111:B4, Sigma) or live M. tuberculosis H37Rv 
bacteria (MOI 2:1) for 90 min, 150 min, 300 min, 24 h, and 48 h.  Supernatants were 
collected and analysed for cytokine content using ELISA and nitrite concentration using 
the Griess reagent (3% phosphoric acid, 1% p-aminobenzene-sulphonamide, 1% n-















Bioactive TNF assay 
Bioactive TNF was determined using TNF sensitive fibroblast cell line WEHI 164, clone 
13 (Walter and Eliza Hall Institute).  WEHI cells were cultured on 90 mm tissue culture 
petridish (Bibby Sterilin, UK) in RPMI (Sigma, Germany) in 10% FCS (Gibco, 
Invitrogen Corporation, Germany) containing 10 U/ml penicillin (Gibco, Invitrogen 
Corporation, Germany), 10 µg/ml streptomycin (Gibco, Invitrogen Corporation, 
Germany) and 0.5x amino acid supplement (Gibco, MEM Amino acids without L-
glutamine, Invitrogen Corporation, Germany) until confluent.  Adherent cells were 
harvested using PBS (Appendix) containing Trypsin-EDTA (Gibco, Invitrogen 
Corporation, Germany), washed in PBS (Appendix) then centrifuged at 405 RCF.  Cells 
were resuspended in RPMI (Sigma, Germany) containing 10% FCS (Gibco, Invitrogen 
Corporation, Germany), 100 U/ml penicillin (Gibco, Invitrogen Corporation, Germany) 
and 100 ng/ml streptomycin (Gibco, Invitrogen Corporation, Germany) and plated at 
2x105 cells/ml in 96 well tissue culture plates (Nunclon, Denmark) and incubated for 24 h 
at 37°C and 5% CO2 to allow for cell adherence.  TNF standards (recombinant mouse 
TNF, BD PharMingen, San Diego) prepared in 2 fold serial dilutions starting at 8 pg/ml 
to 0.016 pg/ml or samples were added to WEHI cells and incubated for 18 h at 37°C and 
5% CO2.  Fifty microliters of 2 mg/ml MTT (Sigma, Germany) solution was added and 
cells were incubated for further 2 h, after which, the supernatants were aspirated and 50 
µl DMSO was added and samples were read at 570 nm using VERSAmax Tunable 
Microplate Reader (Molecular devices Corporation, California, USA).  Data was 
analysed using SoftMax Pro Version 4.3 software (Molecular devices Corporation, 












Antigen-specific IFN-γ production 
Antigen-specific production of IFNγ was measured from single cell suspension of 
mediastinal lymph nodes, lungs or BAL prepared from infected mice at specific time 
points after infection with M. tuberculosis H37Rv.  Cells were resuspended in RPMI 
(Sigma, Germany) supplemented with 10% FCS (Gibco, Invitrogen Corporation, 
Germany), 100 U/ml penicillin (Gibco, Invitrogen Corporation, Germany) and 100 µg/ml 
streptomycin (Gibco, Invitrogen Corporation, Germany) then cultured at 5x105 cells/well 
in 96 well round-bottom microplates (Nunc, Naperville, IL), and stimulated with either 
10 µg/ml ESAT-6 (Statens, Serum Institut, Denmark), 5 µg/ml anti-CD3/CD28 (BD 
PharMingen, San Diego) live M. tuberculosis H37Rv (MOI 2:1) and incubated at 37°C 




Data were analysed by comparison of WT and gene-deficient/transgenic mice at specific 
time points and expressed as mean ± SD of 4mice/group (unless stated otherwise).  All 
graphic results were prepared using the GraphPad Prism 4 software and the same 
software was used for statistical analysis of data (Student‘s t test for comparison of two 
groups and ANOVA for comparison of three groups or more) and comparative analysis 
of survival data using designated GraphPad Prism 4 statistical module.  p values ≤ 0.05 






















































The inherent complexity of TNF-mediated protective immunity and TNF-mediated immune pathologies is 
implicit in the differential bioactivities of the two molecular forms of TNF (solTNF and Tm-TNF) and the 
differential functioning of its receptors (p55TNFR and p75TNFR).  The purpose of this study was to 
characterize the role(s) of soluble TNF and membrane bound TNF in protective or pathology mediated 
TNF responses against M. tuberculosis lung infection.  Because of the progressive nature of M. 
tuberculosis infection this chapter addressed three different phases of tuberculosis disease: acute infection, 




















Section I: Tm-TNF and acute M. tuberculosis infection 
 
Summary 
The fundamental importance of TNF in immunity against M. tuberculosis has been 
demonstrated previously but the contribution of soluble TNF versus membrane bound 
TNF in this immunity has not been fully characterized.  In this chapter, we demonstrate 
that Tm-TNF mediate protective immune responses against low dose aerosol inhalation 
challenge with M. tuberculosis H37Rv.  We demonstrate that Tm-TNF mice produce 
normal levels of IL-12p70, IFNγ and IL-10 and mediate a normal inflammatory process 
comparable to WT control mice.  Bactericidal granuloma structure formation is possible 
in the presence of Tm-TNF molecule and these are composed of activated CD4+ T cells 
and activated macrophages.  In conclusion, membrane expressed TNF is sufficient to 






















Tm-TNF mice control acute M. tuberculosis infection. 
Previous gene deletion and neutralization studies showed that TNF is required for 
generation of protective immunity during infection with a non-virulent mycobacterial M. 
bovis BCG strain (Jacobs et al., 2000b; Kindler et al., 1989).  However, these studies did 
not characterize the relative contributions of the two molecular forms of TNF: Tm-TNF 
and solTNF in this process.  A study by Olleros et al., (2002; 2005) revealed that 
transgenic mice expressing Tm-TNF in the absence of TNF and LTα developed 
protective immune responses against M. bovis BCG as well as M. tuberculosis however; 
the control of bacilli replication observed for M. bovis BCG was less efficient for M. 
tuberculosis infection.  Dissecting the functions of Tm-TNF versus those of solTNF in 
these transgenic mice is further complicated by the fact that LTα has also been reported 
to mediate partial protection against M. bovis BCG infection (Bopst et al., 2001).  We 
examined the respective roles of solTNF and Tm-TNF using Tm-TNF mice in which the 
endogenous TNF allele was replaced with an uncleavable form of TNF but retained 
normal cell surface expression and functional capacity of WT Tm-TNF molecule (Ruuls 
et al., 2001).  In a study where mice were challenged with 1x106 CFUs/mouse via the 
intranasal route, we found that Tm-TNF mice were rendered susceptible to M. bovis BCG 
infection reflected by significant bacilli burdens in the lungs, spleens and livers compared 
to WT mice (Dambuza et al., 2008).  To determine the effects of virulence on Tm-TNF 
mediated immunity in a natural M. tuberculosis aerosol inhalation challenge model; WT 
mice, TNF-/- mice and Tm-TNF mice were infected with 100 CFUs/mouse M. 












markers of disease progression.  WT mice maintained consistent body weights (Fig. 1A) 
throughout the experimental period and no mortalities were recorded (Fig. 1B).  In sharp 
contrast, TNF-/- mice were highly susceptible to infection, displayed rapid weight loss 
(Fig. 1A) and succumbed to infection with a mean survival time of 44 days (Fig. 1B) 
which was significantly different (p < 0.05) from WT control mice.  Conversely, Tm-
TNF mice maintained body weights comparable to WT mice (Fig. 1A) and displayed 









































Figure 1.  Tm-TNF mice are protected from acute M. tuberculosis infection.  WT mice (black circles), 
TNF-/- mice (white diamonds) and Tm-TNF mice (white squares) were infected with 100 CFUs/mouse M. 
tuberculosis H37Rv by aerosol inhalation.  (A) Body weights and mortality rates (B) were assessed over 
the infection period.  Data represent 1 out of 2 experiments performed and are expressed as mean ± SD of 8 




















































Control of mycobacterial replication was then assessed in the lungs and spleens of mice.  
As shown in Fig. 2A, bacterial replication in WT mice increased logarithmically and 
reached 6.5 log10 by day 26 post-infection then decreased to 5 log10 by day 33 post-
infection.  Bacilli burdens were then maintained at this level until the experiment was 
terminated 52 days post-infection.  In TNF-/- mice however, bacilli growth in the lungs 
was unrestricted and by day 33 post-infection bacilli burdens reached 8.5 log10 CFUs and 
were significantly higher (p < 0.001) in comparison to WT mice (Fig. 2A).  The increased 
bacilli burdens in the lungs of TNF-/- mice corresponded with the early susceptibility to 
infection seen in this strain (Fig. 1A & B).  Interestingly, Tm-TNF mice displayed a 
bacilli growth kinetic comparable to that of WT mice (Fig. 2A).  Spread of mycobacteria 
to spleen was determined and a significant difference (p < 0.01) in bacterial numbers was 
observed as early as day 26 post-infection in TNF-/- mice compared to WT mice and by 
33 days post-infection, the bacilli numbers declined in both strains but were observed to 
be higher in TNF-/- mice (Fig. 2B).  Conversely, bacilli numbers were comparable 
between Tm-TNF mice and WT mice at day 26 post-infection and followed a similar 
mycobacterial growth kinetic determined day 33 and day 52 post-infection, no significant 
differences were observed (Fig. 2B).  Differences in bacterial burdens in the lungs were 
confirmed histologically by Ziehl-Neelson staining with mycobacteria in WT mice (Fig. 
2C) largely localized intracellularly, in contrast, there was a significant amount of 
extracellular bacilli in TNF-/- mice (Fig. 2D) at day 33 post-infection.  Conversely, in Tm-
TNF mice (Fig. 2E) the bacterial staining pattern was similar to WT mice with bacilli 




































































Figure 2.  Tm-TNF is adequate for control of the infection.  WT mice (black circles), TNF-/-  mice (white 
diamonds) and Tm-TNF mice (white squares) were aerosol-infected with 100 CFUs/mouse M. tuberculosis 
H37Rv and bacilli burdens were assessed in the lungs (A)  and spleens (B) at time points indicated.  Lung 
sections from WT mice (C), TNF-/- mice (D) and Tm-TNF mice (E) were analyzed for presence of 
mycobacteria by Ziehl-Neelson staining at day 33 pots-infection (arrows show acid-fast bacilli).  Data are 
expressed as mean ± SD of 4 animals/group and represent 1 of 3 experiments performed.  Significant 
differences (***p < 0.001; **p < 0.01) were obtained using ANOVA.  Micrographs represent 4 





















































Tm-TNF mediates controlled inflammatory response and protective granuloma 
formation during acute M. tuberculosis infection. 
Mycobacterial granulomas are focal accumulations of mononuclear cells that form 
organized structures with centrally located macrophages that differentiate into epitheloid 
cells surrounded by lymphocytic aggregates, mainly CD4 T cells and this colocation is 
thought to allow close antigen-specific T cell-macrophage interaction facilitating 
activation of bactericidal mechanisms (Flynn and Chan, 2001).  TNF is essential for the 
formation and maintenance of the granulomas and many studies have shown that TNF 
plays a role in the early induction of chemokines and regulation of cell adhesion 
molecules that facilitate initial leukocyte recruitment and aggregation resulting in 
granuloma formation (Hickey et al., 1997; Mulligan et al., 1993; Roach et al., 2002).  We 
therefore investigated whether Tm-TNF signaling induced granuloma structure 
formation.   
 
Initially, we assessed lung weights in infected WT mice, TNF-/- mice and Tm-TNF mice 
as a surrogate marker of inflammation.  WT mice displayed a steady slight increase in 
lung weights of about 0.1 g over the course of the infection period (Fig. 3.1A).  Lung 
weights were comparable to WT mice determined 26 days post-infection in TNF-/- mice, 
but a significant increase (p < 0.05) was observed at day 33 post-infection in TNF-/- mice 
(Fig. 3.1A).  In contrast, Tm-TNF mice showed similar lung mass comparable to WT 
mice at time points investigated (Fig. 3.1A).  Total lung cell counts were then determined 
at day 33 post-infection to confirm lung weight data.  Results obtained showed that TNF-












contrast, Tm-TNF mice displayed lung cell numbers comparable to WT mice (Fig. 3.1B).  
Together, these results suggest that Tm-TNF is sufficient to mediate early inflammatory 
response during M. tuberculosis infection and complete absence of TNF results in 














































Figure 3.1.  Tm-TNF mediates a controlled cell infiltration in the lung.  WT mice (black circles), TNF-/- 
mice (white diamonds) and Tm-TNF mice (white squares) were infected by aerosol inhalation with 100 
CFUs/mouse M. tuberculosis H37Rv and lung weights (A) were determined at specific time points.  (B) 
Lung single cells suspensions were prepared and total cell numbers were quantified 35 days post-infection. 
Data are expressed as mean ± SD of 4 animals/group and represent 1 of 3 experiments performed.  




























































Next, we assessed whether granulomas were formed in presence of Tm-TNF as a 
correlate of protection.  Depicted in Fig. 3.2, results obtained showed that WT mice 
formed compact well defined granulomas consisting of epitheloid macrophages and 
interspersed with recruited lymphocytes analyzed at day 26 (Fig. 3.2A) and day 33 (Fig. 
3.2D) post-infection and interestingly, granulomas formed in TNF-/- mice (Fig. 3.2B) 
analyzed 26 days post-infection, however, the lesions increased in size by day 33 post-
infection (Fig. 3.2E) becoming more diffuse and involving larger areas of the lung 
compared to WT mice granuloma.  In converse, Tm-TNF mice formed well-structured 
granulomas comparable to WT mice analyzed 26 days and 33 days post-infection (Fig. 
3.2C & F, respectively).  These observations are in line with published reports (Fremond 
et al., 2005; Saunders et al, 2005) and illustrate that Tm-TNF is sufficient to mediate 
granuloma structure formation that protects mice from acute M. tuberculosis H37Rv 
infection not observed in complete lack of TNF.  
 
We then investigated the expression of cell adhesion and cell homing molecules as 
determinants for failure to form compact granulomas in TNF-/- mice.  Lung single 
suspensions were generated from infected WT mice, TNF-/- mice and Tm-TNF mice 21 
days post-infection and cell surface expression levels of CD11a, CD49a and CD69L on 
CD4+ T cells (gating strategy, Fig. 3.3.i) were determined by measuring the mean 
fluorescent intensity using flow cytometry.  Results obtained showed that there was a 
slight but insignificant increase in percentage of CD4+ T cells in TNF-/- mice compared to 
WT mice but conversely, the percentage of CD4+ T cells present in Tm-TNF mice was 












observed in the level of surface expression of all the leukocyte adhesion and trafficking 
molecules investigated (Fig. 3.3.iiB, C & D).  These results suggest the expression of 





















































Figure 3.2.  Tm-TNF contributes to granuloma formation during acute M. tuberculosis infection.  WT 
mice (A & D), TNF-/- mice (B & E) and Tm-TNF mice (C & F) were infected by aerosol inhalation with 
100 CFUs/mouse M. tuberculosis H37Rv and lung sections were removed 26 days post-infection (left 
column) and 33 days post-infection (right column) and stained with haematoxylin and eosin (arrows 






































Figure 3.3.i.  Gating strategy.  Lung single cell suspensions derived from WT mice, TNF-/- mice and Tm-
TNF mice were prepared 21 days after aerosol infection with 100 CFUs/mouse M. tuberculosis H37Rv.  
Cells were stained with irrelevant antibody (IgG) or anti-CD4 antibody and the MFIs of CD11a, CD49a 









































Figure 3.3.ii.  Tm-TNF mediates a controlled frequency of pulmonary CD4+ T cells but does not 
influence cellular adhesion and action markers.  WT mice (black bars), TNF-/- (white bars) mice and Tm-
TNF (striped bars) mice were challenged by aerosol inhalation infection with 100 CFUs/mouse M. 
tuberculosis H37Rv.  Lung single cell suspensions derived from respective mice groups at 21 days post-
infection were stained for CD4, CD11a, CD49a or CD62L expression then analyzed by flow cytometry.  
The frequency of CD4+ T cells (A) and the mean surface expression levels (MIFs) of CD11a+ (B), CD49a+ 
(C) and CD62L+ (D) gated on CD4+ T cell subpopulation were determined.  The data is representative of 1 
of 2 experiments performed and the results are expressed as mean ± SD of 4 animals/group.  Significant 



















































































































Tm-TNF is sufficient to facilitate influx of activated pulmonary CD11b+ cells and 
CD4+ T cells during acute M. tuberculosis infection.   
Next we used flow cytometry to characterize the influx of cells into the lung.  Studies 
have shown that one of the earliest events upon antigen uptake and activation of antigen 
presenting cells is the upregulation of cell surface expression of co-stimulatory (CD80 
and CD86) and activation markers such as MHC-II and CD40 and their expression levels 
were observed to increase after M. tuberculosis infection (Gonzalez-Juarrero et al., 2003).  
Here, we compared the frequency of lung CD11b+ cells (in murine experimental 
pulmonary tuberculosis, expressed on macrophages, monocytes, dendritic cells, 
granulocytes, B and T cells) in WT mice, TNF-/- mice and Tm-TNF mice at day 35 post-
infection.  Data obtained revealed that compared to WT mice, TNF-/- mice had 
significantly increased (p < 0.001) percentage of CD11b+ cells whereas Tm-TNF mice 
displayed a comparable frequency of CD11b+ cells to WT mice (Fig. 4.1.iiA).  We then 
assessed the mean surface expression of MHC-II, CD80, and CD86 gated on CD11b+ 
cells (gating strategy, Fig. 4.1.i).  TNF-/- mice displayed significant increase in surface 
expression of MHC-II (Fig. 4.1.iiB, p < 0.01) and CD80 (Fig. 4.1.iiD, p < 0.001) 
compared to WT mice, CD86 expression (Fig. 4.1.iiC) although higher in TNF-/- mice 
relative to WT mice did not reach statistical significance.  These data correlates with the 
increased bacilli burdens in the lungs of TNF-/- mice (Fig. 2A).  Interestingly, in Tm-TNF 
mice, MHC-II (Fig. 4.1.iiB), CD86 (Fig. 4.1.iiC), and CD80 (Fig. 4.1.iiD) surface 
expression was equivalent to WT mice.  These data suggest that during acute M. 
tuberculosis infection, Tm-TNF contributes to the recruitment of CD11b+ cells to the 












bacterial growth.  In addition the excess influx of these cells and their hyperactivation 























































Figure 4.1.i.  Gating strategy.  Lung single cell suspensions derived from WT mice, TNF-/- mice and Tm-
TNF mice were prepared 35 days after aerosol infection with 100 CFUs/mouse  M. tuberculosis H37Rv.  
Cells were stained with irrelevant antibody (IgG) or anti-CD11b and the MFIs of MHC-II, CD86 and CD80 













































Figure 4.1.ii.  Tm-TNF is sufficient to facilitate influx of CD11b+ cells and cell activation.  WT mice 
(black bars), TNF-/- (white bars) mice and Tm-TNF (striped bars) mice were challenged by aerosol 
inhalation infection with 100 CFUs/mouse M. tuberculosis H37Rv.  Lung single cell suspensions derived 
from respective mice groups at 35 days post-infection were stained for CD11b expression and analyzed by 
flow cytometry.   The frequency of CD11b+ cells (A) and the mean surface expression levels (MFIs) of 
MHC-II (B), CD86 (C), and CD80 (D) gated on CD11b+ cell subpopulation was determined.  The data are 
representative of 1 of 2 experiments performed and the results are expressed as mean ± SD of 4 
























































































































Several studies have shown that the destructive pathology observed in TNF deficient 
mice involved presence of large quantities of activated Th1 cells at sites of M. 
tuberculosis infection (Saunders et al., 2005; Zganiacz et al., 2004).  Lung single 
suspensions were generated from WT mice, TNF-/- mice and Tm-TNF mice 35 days post-
infection and the numbers of CD4+ T cells infiltrating the lung and their activation state 
reflected by cell surface expression of CD44 on CD4+ T cells (gating strategy, Fig. 4.2.i) 
was determined by flow cytometry.  We confirmed previous reports demonstrating that 
compared to WT mice, TNF-/- mice displayed significantly increased (p < 0.01) lung 
CD4+ T cell numbers (Fig. 4.2.iiA) with an activated phenotype shown by the increased 
mean cell surface expression of CD44 molecule (Fig. 4.2.iiB) analyzed 35 days post-
infection, in contrast, Tm-TNF mice displayed comparable CD4+ T cell numbers (Fig. 
4.2.iiA) infiltrating the lung with similar activation state to WT mice (Fig. 4.2.iiB).  Thus 
dysregulated pulmonary CD4+ T cell influx and hyperactivation is corrected by presence 
of Tm-TNF molecule.  However, the increased frequency and the increased activation 
status of antigen presenting cells may facilitate the heightened Th1 immune response in 












































Figure 4.2.i.  Gating strategy.  Lung single cell suspensions derived from WT mice, TNF-/- mice and Tm-
TNF mice were prepared 35 days after aerosol inhalation infection with 100 CFUs/mouse M. tuberculosis 
H37Rv.  Cells were stained with irrelevant antibody (IgG) or anti-CD4 and the MFIs of CD44 gated on 





































Figure 4.2.ii.  Tm-TNF mediates a controlled frequency and cellular activation of pulmonary CD4+ T 
cells.  WT mice (black bars), TNF-/- (white bars) mice and Tm-TNF (striped bars) mice were challenged by 
aerosol inhalation infection with 100 CFUs/mouse M. tuberculosis H37Rv.  Lung single cell suspensions 
derived from respective mice groups at 35 days post-infection were stained for CD4 or CD44 expression 
then analyzed by flow cytometry.  The frequency of CD4+ T cells (A) and the mean surface expression 
levels (MFIs) of CD44 (B) gated on CD4+ T cell subpopulation was determined.  The data are 
representative of 1 of 2 experiments performed and the results are expressed as mean ± SD of 4 










































































Controlled pulmonary cytokine induction and iNOS expression during acute M. 
tuberculosis infection in Tm-TNF mice.  
Previous studies have shown that both TNF and IFN are required for optimum 
macrophage activation and that IL-10 regulates Th1 responses during mycobacterial 
infection (Frankova and Zidek, 1998; Jacobs et al., 2000a).  IL-12 has been implicated in 
previous reports as the key factor for the release of IFNγ by NK cells (Natural killer cells) 
and Th1 cells (Hsieh et al., 1993; Oswald et al., 1994).  Furthermore, it has been shown 
that mice deficient of IL-12 are highly susceptible to mycobacterial infection due to 
impaired Th1 cytokine responses and defective granuloma formation (Cooper et al., 
1997; Wakeham et al., 1998).  We therefore examined pulmonary levels of IFN, IL-
12p70 and IL-10 secretion as determinants of induction and regulation of Th1 immunity 
during acute M. tuberculosis challenge.  Lungs were obtained from infected mice and 
cytokine production was assessed by ELISA at day 35 post-infection; at which point 
TNF-/- mice displayed susceptibility to infection.  Data obtained showed that pulmonary 
IL-12p70 levels were significantly higher (p < 0.05) in TNF-/- mice compared to WT mice 
at day 35 post-infection,  in contrast, Tm-TNF mice  displayed comparable levels to WT 
mice (Fig. 5A).  IFN levels were found to be 100x higher (p < 0.001) in TNF-/- mice 
compared to WT control mice at day 35 post-infection but in converse, the levels of IFNγ 
were similar between WT mice and Tm-TNF mice (Fig. 5B).  Interestingly, the 
concentration of IL-10  was found to be significantly higher (p < 0.01) in moribund TNF-
/- mice relative to WT mice 35 days post-infection  but was comparable between Tm-TNF 
mice and WT mice (Fig. 5C).  Therefore, these data suggest that cell surface TNF 












required for the negative regulation of this response and in its absence hyper immune 
activation which is not down regulated by IL-10, drive immunopathology.  We therefore, 
investigated iNOS expression as a contributory factor to susceptibility of TNF-/- mice.  
  
Previous reports have shown that TNF is central for macrophage activation that leads to 
mycobacterial killing through iNOS dependent and independent mechanisms (Appelberg 
et al., 1995; Bekker et al., 2001).  Lung sections from infected WT mice, TNF-/- mice and 
Tm-TNF mice were stained for iNOS expression 33 days post-infection.  Data obtained 
revealed that iNOS was expressed in all the respective mice and the expression pattern 
was associated with granuloma lesions (Fig. 5.D, E & F).  These data suggest data iNOS 
induction on its own is insufficient for controlling mycobacterial growth if the granuloma 
structure is not properly formed.   
 
Therefore, together the data presented here show that TNF deficiency mediates excessive 
inflammatory response that results in formation of pathological granulomas that cannot 
contain mycobacterial growth and this phenotype is corrected by the presence of Tm-




































Figure 5.  Pulmonary cytokine production is normal in the presence of Tm-TNF and iNOS is expressed.  
WT mice (black bars), TNF-/- mice (white bars) and Tm-TNF mice (striped bars) were infected with 100 
CFUs M. tuberculosis H37Rv by aerosol inhalation and the concentration of IL-12p70 (A), IFNγ (B) and 
IL-10 (C) were measured by ELISA 33 days post-infection.  Lung sections from WT mice (D), TNF-/- mice 
(E) and Tm-TNF mice (F) were removed 33 days post-infection and with polyclonal rabbit anti-mouse 
antibody.  The brown stain represents iNOS expression by activated macrophages.  Data are expressed as 
mean ± SD of 4 animals/group and represent 1 of 3 experiments performed.  Significant differences (***p 
< 0.001; **p < 0.01; *p < 0.05)) were obtained using ANOVA.  Micrographs represent 4 animals/group 

















































































Section II: Tm-TNF and chronic M. tuberculosis infection 
 
Summary 
This study investigated the contribution(s) of solTNF and Tm-TNF during chronic M. 
tuberculosis infection.  We report here that Tm-TNF was insufficient to control chronic 
infection with low dose aerosol inhalation challenge with virulent M. tuberculosis H37Rv 
as reported for the avirulent M. bovis BCG infection (Dambuza et al., 2008).  We 
demonstrate that Tm-TNF mice displayed excess pulmonary and systemic inflammatory 
response following chronic exposure to M. tuberculosis with enhanced cell surface 
expression of MHC-II, CD80 and CD86 on CD11b+ cells in the lungs.  Also, we illustrate 
that granulomas formed in Tm-TNF mice appeared larger involving high proportions of 
the lung and iNOS expression pattern was dispersed compared to WT control mice 
resulting in failure to inhibit mycobacterial growth followed by demise of animals.  In 
conclusion, Tm-TNF is not enough to sustain long term protection against chronic M. 
tuberculosis infection and we suggest that solTNF may be required to regulate excess 





















Persistent virulent M. tuberculosis infection is lethal in Tm-TNF mice. 
Experimental work conducted in our laboratory using a high dose intranasal challenge 
(1x106 CFUs) with non-virulent strain M. bovis BCG revealed that, despite a 
compromised immune response reflected by high bacilli burden in Tm-TNF mice tissues, 
chronic infection was not lethal.  To determine whether Tm-TNF expression alone could 
provide protection against chronic infection with a virulent strain, WT mice and Tm-TNF 
mice were exposed to a low dose aerosol infection with 100 CFUs/mouse M. tuberculosis 
H37Rv.  Mortality rates observed showed that persistent M. tuberculosis infection 
resulted in lethality in Tm-TNF mice with a mean survival time of 189 days compared to 
WT mice which displayed resistance to infection until the experiment was terminated 350 
days post-infection (Fig. 1A).  These data show that Tm-TNF does not afford long lasting 
protection against M. tuberculosis infection. 
 
To dissect the components of Tm-TNF lethality to chronic infection, host immune 
responses were assessed.  Firstly, the ability of mice to control bacilli growth during a 
chronic infection was investigated.  WT mice and Tm-TNF mice were killed at specific 
time points during the infection period and the number of bacilli in the lungs and spleens 
were determined.  Saunders et al., (2005), using the same Tm-TNF knock-in mouse, 
reported that membrane bound TNF was sufficient to induce mycobactericidal responses 
evidenced by equivalent bacilli burdens between WT mice and Tm-TNF mice 16 weeks 
post-infection.  We report here that indeed, comparable to WT mice, Tm-TNF mice 












days post-infection.  However, by 154 days post-infection, there was a significant 
increase in bacilli numbers in the lungs (p < 0.05) and spleens (p < 0.01) (Fig. 1C & 1E, 
respectively) of Tm-TNF mice compared  to WT mice.  These data demonstrate that Tm-
TNF signal alone is not sufficient to induce protective anti-mycobacterial immune 




















































Figure 1.  Tm-TNF mice display susceptibility to chronic infection.  WT mice (black circles) and Tm-
TNF mice (white squares) were infected with 100 CFUs/mouse M. tuberculosis H37Rv by aerosol 
inhalation.  (A) Mortality rates, Tm-TNF mice succumb by day 189 post-infection.  Data represent 1 of 2 
experiments performed and are expressed as mean ± SD of 8 mice/group.  Bacilli burdens were determined 
in the lungs (B & C) and spleens (D & E) of infected mice at time points indicated, where C and E 
represent samples obtained 154 days post-infection.  Significant differences (*p < 0.05; **p < 0.01) were 
obtained using the Student‘s  t test, for % survival the Log Rank test was used for curve comparison. 



































































































Uncontrolled inflammatory responses in Tm-TNF mice chronically infected with M. 
tuberculosis. 
TNF is important for maintenance of protective immunity against chronic M. tuberculosis 
infection.  A study conducted by Mohan et al., (2001), revealed that TNF neutralization 
in mice chronically infected with M. tuberculosis resulted in histopathological features 
indicative of an enhanced inflammatory response in the lungs of infected mice which 
included increased cellularity, squamous metaplasia and granuloma disintegration.  In 
another study, TNF blockade during chronic tuberculosis infection resulted in increased 
expression of pro-inflammatory cytokines and chemokines in the lungs (Chakravarty et 
al., 2008).  To determine the role of Tm-TNF in mediating an inflammatory response in a 
persistent M. tuberculosis infection, organs were harvested from infected mice and 
weights were recorded as a surrogate marker of inflammation.  Results obtained showed 
that during early infection (≤ 50 days post-infection), Tm-TNF mice controlled 
pulmonary inflammation similar to WT mice but displayed significant lung mass increase 
(p < 0.05) at 118 days and 154 days post-infection (Fig. 2A).  The observed increased 
lung mass, particularly at day 118 did not correlate with an increased bacilli burden in the 
lungs of Tm-TNF mice at this time point (Fig. 1B).  This finding was important as it 
suggested that the confounding factor for excess inflammation was not an increase in the 
number of bacilli in the lung.  In addition, systemic inflammation reflected by 
splenomegaly was evident as early as 35 days post-infection and, although not 
significant, was found to be higher in Tm-TNF mice compared to WT mice (Fig. 2B) and 












infection in Tm-TNF mice (Fig. 2B).  These data show that Tm-TNF alone is not 
sufficient for control of inflammation during persistent M. tuberculosis infection. 
 
We then asked whether granuloma structure was maintained as a correlate of 
susceptibility in Tm-TNF mice during chronic infection.  Results obtained revealed that 
granuloma formation was characterized by distinctly defined structures in WT mice (Fig. 
2C) whereas, granulomas form in Tm-TNF mice were larger in size with large areas of 
the lung tissue involved in inflammation (Fig. 2D) analyzed 154 days post-infection.  
These data support observations by previous reports (Fremond et al., 2005; Saunders et 
al., 2005).  Therefore, these results suggest that Tm-TNF signal alone is not enough to 
maintain protective granuloma formation suggesting that solTNF may be required to 












































Figure 2.  Tm-TNF is not sufficient to control inflammatory response during chronic M. tuberculosis 
infection.  WT mice (black circles) and Tm-TNF mice (white squares) were exposed by aerosol inhalation 
to 100 CFUs/mouse M. tuberculosis H73Rv.  (A) Lung and spleen (B) weights were recorded at time points 
shown to monitor inflammation.  Lung sections were removed from WT mice (C) and Tm-TNF mice (D) 
169 days post-infection and stained with haematoxylin and eosin.  Data are expressed as the mean ± SD of 
4 mice/group.  Results represent 1 of 3 similar experiments.  Significant differences (*p < 0.05) were 





















































Enhanced activation of lung infiltrating CD11b+ cells in chronic M. tuberculosis 
infected Tm-TNF mice. 
Next we compared the level of activation of lung infiltrating macrophages in WT mice 
and Tm-TNF mice during chronic M. tuberculosis infection.  Previous studies have 
associated increased macrophage activation with the induction of severe tissue injury 
(Laskin and Pendino, 1995).  In addition, Guler et al., (2004), showed that enhanced 
iNOS production induced tissue injury during mycobacterial infection.  We therefore 
assessed the expression of MHC-II, CD80 and CD86 on CD11b+ cells as indicators of 
cellular activation and the level of iNOS expression in WT mice and Tm-TNF mice 
during chronic infection.  Data obtained revealed that the frequency of CD11b+high 
expressing cells (gating strategy, Fig. 3.1.i) was equivalent in both strains (Fig. 3.1.iiA).  
However, the analyses of cell surface expression levels of MHC-II (Fig. 3.1.iiB), CD86 
(Fig. 3.1.iiC) and CD80 (Fig. 3.1.iiC) gated on CD11b+high cells showed an increase (p < 
0.05) in the mean fluorescence intensity for all three cellular markers in Tm-TNF mice 
compared to WT mice.  iNOS expression pattern was compact and localized to 
translucent epitheloid macrophage cells confined to well-structured granulomas within 
lungs of WT mice (Fig. 3.2A).  In contrast, lungs of Tm-TNF mice showed a dispersed 
staining pattern of iNOS expression reflecting the dissolute granuloma structure (Fig. 
3.2B).  These data indicate that Tm-TNF mediate an increased pulmonary macrophage 






























Figure 3.1.i.  Gating strategy.  Lung single cell suspensions derived from WT mice and Tm-TNF mice 
were prepared 169 days after aerosol infection with 100 CFUs/mouse M. tuberculosis H37Rv.  Cells were 
stained with irrelevant antibody (IgG) or anti-CD11b and the MFIs of MHC-II, CD80 and CD86 gated on 









































Figure 3.1.ii.  Tm-TNF mediate increased macrophage activation during chronic M. tuberculosis 
infection.  WT mice (black bars) and Tm-TNF mice (striped bars) were exposed by aerosol inhalation to 
100 CFUs/mouse M. tuberculosis H73Rv.  The frequency of CD11b+ cells (A) infiltrating the lung was 
determined at day 169 post-infection.  The mean surface expression levels (MFIs) of MHC-II (B), CD86 
(C) and CD80 (D) on CD11b+ cells was analyzed by flow cytometry.  Data represent 1 of 2 similar 
experiments and are expressed as the mean ± SD of 4 mice/group.  Significant differences (*p < 0.05) were 


























































































































Figure 3.2.  Enhanced iNOS expression in Tm-TNF mice during chronic infection.  WT mice and Tm-
TNF mice were challenged via aerosol inhalation with 100 CFUs/mouse M. tuberculosis H37Rv.  Lungs 
were obtained at day 169 post-infection and immunohistochemical staining was performed with polyclonal 
rabbit anti-mouse antibody.  The brown stain is indicative of iNOS-positive macrophages.  Micrographs 




















Increase in inflammatory cytokines mediates a non-protective immune response in Tm-
TNF mice chronically infected with M. tuberculosis.  
IL-12 and IFNγ have been shown to be important for protective immunity against M. 
tuberculosis infection because of the roles they have in activating and development of 
Th1 T cells (Cooper et al., 1993; Cooper et al., 1995).  Additionally, IFNγ has been 
reported to collaborate with TNF for optimum macrophage activation for killing of 
intracellular pathogens including mycobacteria (Ding et al., 1988; Flesch and Kaufmann, 
1990).  Chakravarty and colleagues (2008) showed that in mice chronically infected with 
M. tuberculosis, TNF neutralization resulted in increased lung mRNA expression of IL-
12p40 and IFNγ, suggesting an anti-inflammatory role for TNF.  We quantified the 
concentration of IL-12p70 and IFNγ in relation to susceptibility observed in Tm-TNF 
mice during chronic M. tuberculosis infection.  Lungs from infected mice were harvested 
at specific time points and the quantity of IL-12p70 and IFNγ was determined by ELISA.  
Shown in Figure 4A, the amount of IL-12p70 in Tm-TNF mice was slightly higher than 
WT mice with no significant difference attained at 154 days post-infection.  In both 
groups, the levels of IL-12p70 declined by day 169 post-infection but Tm-TNF mice had 
significantly higher (p < 0.01) concentration compared to WT mice (Fig. 4A).  IFNγ 
levels were found to be significantly higher in Tm-TNF mice compared to WT mice at 
154 days (p < 0.01) and 169 days (p < 0.05) post-infection (Fig. 4B).  These data support 
the earlier observation of increased inflammatory response in Tm-TNF mice (Fig. 2A).  
Next, we measured the level IL-10 because of its reported ability to down modulate Th1 
responses (Gong et al., 1996).  Results obtained showed comparable IL-10 levels at  day 












in IL-10 concentration was observed in Tm-TNF mice at day 169 post-infection (Fig. 
4C).  These data suggest that in absence of solTNF, increased IL-12p70 and IFNγ 
mediate excessive inflammation during the late stages M. tuberculosis infection and the 




















































Figure 4.  Increased cytokine production in Tm-TNF mice during chronic M. tuberculosis infection.  
WT mice (black bars) and Tm-TNF mice (striped bars) were challenged by aerosol inhalation with 100 
CFUs/mouse M. tuberculosis H37Rv.  Lungs were obtained from infected mice at 154 days and 169 days 
post-infection and the amount of IL-12p70, IFNᵧ and IL-10 present in the homogenates was determined by 
ELISA.  Data are a representation of 3 similar experiments and the values are expressed as mean ± SD of 4 






































































Section III: Tm-TNF and M. tuberculosis reactivation murine model 
 
Summary 
This study investigated the contribution(s) made by solTNF and Tm-TNF in immune 
responses generated against reactivation tuberculosis.  We employed a chemotherapy 
induced tuberculosis reactivation model, whereby groups of mice were challenged by 
aerosol infection with low dose M. tuberculosis for three weeks to establish infection 
followed by 25 mg/Kg INH and 25 mg/kg RIF treatment for six weeks in drinking water, 
after which therapy was terminated and tuberculosis reactivation was investigated.  We 
demonstrate that complete absence of TNF results in host susceptibility to M. 
tuberculosis reactivation in the presence of established mycobacteria-specific immunity 
with mice displaying unrestricted bacilli growth and diffused granuloma structures 
compared to WT control mice.  Interestingly, our data illustrate that bacterial re-
emergence in Tm-TNF mice is contained during the initial phases of tuberculosis 
reactivation, sustaining immune pressure in a manner comparable to WT mice.  We 
demonstrate that Tm-TNF mice however, show susceptibility to long term M. 
tuberculosis exposure associated with uncontrolled influx of immune cells in the lungs 
and reduced IL-12p70, IFNγ, enlarged granuloma structures, and failure to contain 
mycobacterial replication relative to WT mice.  In conclusion, we demonstrate that both 
solTNF and Tm-TNF are required for maintaining immune pressure even after 















Tm-TNF protects mice from severe tuberculosis reactivation. 
In a study performed by McCune et al., (1966), it was observed that immunizing mice 
with M. tuberculosis then reinfecting them preceding treatment with anti-tuberculous 
drugs resulted in mice reactivating with lower M. tuberculosis CFU numbers compared to 
control groups.  This result was interpreted as the influence of the host‘s acquired 
immune resistance to mycobacteria.  In this study, we investigated the contribution of 
two molecular forms of TNF, in particular Tm-TNF in host immunity in mice immunized 
by antecedent infection with M. tuberculosis.  The model used entailed aerosol inhalation 
infection of WT mice, TNF-/- mice and Tm-TNF mice with 100 viable M. tuberculosis 
H37Rv bacilli.  The infection was allowed to progress for 21 days before commencement 
of treatment with 25 mg/Kg INH and 25 mg/kg RIF in drinking water for 6 weeks to 
reduce bacilli numbers to at least less than 100 CFUs in the lungs after which treatment 
was withdrawn and tuberculosis reactivation was monitored.  
 
Firstly, body weights were recorded throughout the infection period and body weight loss 
was interpreted as severe disease due to reappearing tuberculosis and correlated with 
susceptibility to infection.  We found that that WT mice showed a steady increase in body 
weights over the duration of the infection in contrast to TNF-/- mice which displayed 
significantly lower body weights (p < 0.05) between 69 days and 116 days post-infection 
(Fig. 1A).  TNF-/- mice also appeared sick with ruffled fur and hunched backs and 
eventually became moribund.  In contrast, Tm-TNF showed an increase in body weights 












weight loss (p < 0.05) was recorded in Tm-TNF mice between 237 days and 265 days 
post-infection while the body weights in WT mice remained stable (Fig. 1A).  For the 
remainder of the experimental period, Tm-TNF mice maintained slightly lower body 
weights relative to WT mice with no significant differences observed (Fig. 1A) but 
exhibited no physical signs of severe disease apparent in TNF-/- mice.  These data indicate 
that complete absence of TNF renders mice susceptible to severe reactivating 
tuberculosis which is alleviated by the presence of Tm-TNF. 
 
Secondly, culturable bacilli numbers in lungs and spleens of infected mice were 
determined at specific time points to investigate the effect of pre-existing immunity on 
recrudescence mycobacteria in WT mice, TNF-/- mice and Tm-TNF mice.  Bacilli 
burdens in WT mice were reduced by 3.5 log10 in the lungs (Fig. 1B) and by 2.5 log10 in 
the spleens (Fig. 1C) after exposure to 6 weeks INH-RIF treatment.  Withdrawal of 
treatment resulted in spontaneous M. tuberculosis reactivation with bacilli burdens 
reaching up to 4 log10 in lungs and 2.5 log10 in the spleens (Fig. 1B & C, respectively).  In 
the contrary, INH-RIF treatment in TNF-/- mice reduced bacilli burdens by 6.5 log10 in the 
lungs (Fig. 1B) and 4.5 log10 in the spleens (Fig. 1C) after 6 weeks exposure.  The 
observed significant reduction in (p < 0.05) bacterial burdens in the lungs of TNF-/- mice 
relative to WT mice after the 6 weeks INH-RIF treatment regimen (Fig. 1B) is consistent 
with published data on the hypothesis that release of immune pressure is intimately 
associated with improved antibiotic-mediated mycobacterial clearance (Horne, 1960).  
Within 70 days post-treatment, mycobacteria reappeared in TNF-/- mice and bacilli 












Interestingly, Tm-TNF mice responded to INH-RIF treatment in a manner comparable to 
WT mice and showed a similar slow kinetic in the rate of reactivation comparable to that 
of WT mice, however, by 259 days post-treatment, bacterial burdens in the lungs of Tm-
TNF mice increased significantly (p < 0.05) by 2 log10 compared to 1 log10 increase 
observed in WT mice (Fig. 1B).  Bacilli burdens in the spleens of Tm-TNF mice were 
found to be comparable to WT mice in all the time points investigated (Fig. 1C).  These 
data show that Tm-TNF plays a role in early bacterial killing mechanisms even after the 
host has encountered M. tuberculosis previously.  And, although Tm-TNF confers 
protection against recrudescence M. tuberculosis, solTNF is crucial for long term control 










































Figure 1.  Progression of M. tuberculosis infection in the presence of specific immunity.  WT mice 
(black circles), TNF-/- mice (white diamonds) and Tm-TNF mice (white squares) were treated for 6 weeks 
with 25 mg/Kg INH and 25 mg/kg RIF in drinking water subsequent to 3 weeks aerosol infection with 100 
M. tuberculosis H37Rv.  (A) Body weights were recorded throughout the course of the infection period and 
bacterial burdens in lungs (B) and spleens (C) were enumerated at time points indicated above.  Data are 
representative of two experiments and data points are expressed as the mean ± SD of 5 mice/group (for 
CFUs).  The body weight study consisted of between 6 – 16 mice/group. Significant differences (*p < 0.05; 
**p < 0.01) were determined by Student‘s t test for comparisons between two groups and ANOVA for 
comparisons between three groups. 



































































Abnormal inflammatory response in the absence of total TNF during tuberculosis 
reactivation is delayed in Tm-TNF mice. 
TNF has previously been shown to be at the apex of inflammatory responses (Algood et 
al., 2005).  To determine whether Tm-TNF was sufficient in mediating an inflammatory 
response during tuberculosis reactivation, mouse lung weights were recorded at specific 
time points during the infection period as a surrogate marker of inflammation.  Compared 
to lung weights determined at day 21 post-infection, WT mice displayed no change in 
lung weights after exposure to INH-RIF for 6 weeks however; an increase in lung 
weights was observed during later stages of disease (322 days post-infection) (Fig. 2.1A) 
which was consistent with the increase in bacilli burdens at this time point (Fig. 1B).  In 
sharp contrast, by 21 days post-infection, TNF-/- mice already displayed significantly (p < 
0.05) higher lung weights compared to WT mice (Fig. 2.1A).  Paradoxically, 63 days 
post-infection at the end of the therapy period, the lung weights had increased 
significantly (p < 0.001) compared to WT mice (Fig. 2.1A) but did not correlate with the 
decreased number of culturable bacilli at this time point (Fig. 1B).  Susceptibility of TNF-
/- mice was confirmed with a further significant increase (p < 0.001) in lung weights 
noted at 113 days post-infection, 50 days after cessation of therapy.  In contrast, 
inflammation in Tm-TNF mice was similar to WT mice during early infection as they 
maintained consistent lung weights at 21 days, 63 days and 133 days post-infection (Fig. 
2.1A).  However, control of inflammation was not sustained as a significant increase (p < 
0.01) in lung weights was evident in Tm-TNF mice at day 322 post-infection compared 







































Figure 2.1.  Induction of excessive inflammation in the absence of solTNF during reactivation of M. 
tuberculosis.  WT (black circles), TNF-/- (white diamonds) and Tm-TNF (white squares) mice were 
exposed by aerosol inhalation infection to 100 CFUs/mouse M. tuberculosis H37Rv for 3 weeks preceding 
chemotherapy with 25 mg/Kg INH and 25 mg/kg RIF for 6 weeks in drinking water.  (A) Lung weights 
were measured at specific time points and BAL derived cell numbers were determined 77 days (B) and 378 
days (C) post-infection.  Data are representative of 1 of 2 experiments performed and are expressed as 
mean ± SD of 5 mice/group.  Significant differences (*p < 0.05; **p < 0.01; ***p < 0.001) were 
determined by Student‘s t test for comparisons between two groups and ANOVA for comparisons between 
three groups. 
 


































































To quantify inflammation in the respective mouse strains, the number of cells in BAL 
(bronchoalveolar lavage) fluid was determined after infection.  The cellularity in the 
lavage fluid was found to be significantly higher (p < 0.01) in TNF-/- mice compared to 
WT mice, whereas, Tm-TNF mice had number of cells comparable to WT mice at day 77 
post-infection (Fig. 2.1B) confirming that the control of inflammation during early 
infection was membrane TNF dependent.  Consistent with lung weights data, Tm-TNF 
mice displayed significantly increased (p < 0.01) number of cells in lavage fluids relative 
to WT mice analyzed at day 378 post-infection (Fig. 2.1C).  Together, these data indicate 
that control of early inflammation is mediated primarily by Tm-TNF but solTNF is 
required for regulation of inflammation during chronic infection.  However, the lack of 
control of inflammation appears to be strongly associated with the onset of tuberculosis 
reactivation. 
 
We next asked whether granuloma structures were formed in the presence of Tm-TNF 
molecule during tuberculosis reactivation.  Studies performed Mohan et al., (2001), 
illustrated that TNF was required for maintenance of granuloma structure during 
persistent M. tuberculosis infection whereby upon treatment with TNF-neutralizing 
antibody, mice displayed severe histopathology marked with excessive inflammation and 
loss of structured granulomas.  Lung sections were obtained from infected WT mice, 
TNF-/- mice and Tm-TNF mice 133 days post-infection and granuloma structures were 
analyzed.  Depicted in Fig. 2.2A, WT mice displayed small compact lesions with tight 
lymphocytic wedges and a high degree of clear airway spaces.  In sharp contrast, TNF-/- 












some evidence of necrosis (Fig. 2.2C).  These findings were congruent with earlier 















































Figure 2.2.  Tm-TNF contributes to protective granuloma formation during M. tuberculosis reactivation.  
WT mice (A & B), TNF-/- mice (C & D) and Tm-TNF mice (E & F) were infected by aerosol inhalation 
with 100 CFUs/mouse M. tuberculosis H37Rv for 3 weeks preceding chemotherapy with 25 mg/Kg INH 
and 25 mg/kg RIF for 6 weeks in drinking water.  Lung sections were removed 113 days post-infection and 
stained with haematoxylin and eosin (A, C & E) to determine the granulomatous response.  Sections B, D 
and F were stained with polyclonal rabbit anti-mouse antibody (see Materials and methods).  The brown 
stain represents iNOS expression by activated macrophages.  Micrographs represent 4 animals/group and 




















In converse, granuloma lesions observed in Tm-TNF were comparable to that of WT 
mice (Fig. 2.2E) analyzed 133 days post-infection.  However, by day 322 post-infection, 
in contrast to WT granulomas (Fig. 2.3A), Tm-TNF displayed larger lesions with excess 
inflammatory response and interstitial pneumonia (Fig. 2.3C).  These observations 
demonstrate that Tm-TNF does not afford long term maintenance of protective 
granuloma structure in the absence of solTNF resulting in malformed lesions that 
associate with failure to inhibit M. tuberculosis growth.  We therefore determined 
whether effector macrophage anti-mycobacterial function was intact in Tm-TNF mice. 
 
Studies have shown that a cell mediated mycobacterial killing function is achieved 
through production of toxic reactive intermediates (RNI) via the enzymatic action of 
macrophage iNOS (Chan et al., 1995; Flynn et al., 1993).  Previously, Flynn et al., 
(1998), demonstrated that inhibition of iNOS in mice chronically infected with M. 
tuberculosis resulted in reactivation of tuberculosis disease with increased organ bacillary 
burdens and extensive granulomatous response.  In view of these findings we determined 
iNOS expression immunohistochemically in lung tissue sections of infected WT mice, 
TNF-/- mice and Tm-TNF mice.  Results obtained demonstrated that iNOS expression 
pattern was largely within the confinement of granuloma lesions in WT mice (Fig. 2.2B) 
in contrast to TNF-/- mice where the pattern was dispersed and associated with the 
diffused granuloma lesions in these mice (Fig. 2.2D) analyzed 133 days post-infection.  
Tm-TNF mice displayed similar iNOS expression at day 133 days post-infection, 
however, later during infection (day 322 post-infection), in contrast to WT mice (Fig. 












and some evidence of lung tissue destruction (Fig. 2.3D).  Therefore, these observations 
indicate data iNOS induction on its own is insufficient for controlling mycobacterial 
growth if the granuloma structure is not properly formed and the increased iNOS 
expression may be harmful to the host.  This is in with line published observations by 
Guler et al., (2004); showing that iNOS-/- mice were protected from tissue damage in M. 































































Figure 2.3.  Tm-TNF is not sufficient to maintain bactericidal granuloma structures during late phase 
M. tuberculosis reactivation.  WT mice (A & B) and Tm-TNF mice (C & D) were infected by aerosol 
inhalation with 100 CFUs/mouse M. tuberculosis H37Rv for 3 weeks preceding chemotherapy with 25 
mg/Kg INH and 25 mg/kg RIF for 6 weeks in drinking water.  Lung sections were removed 322 days post-
infection and stained with haematoxylin and eosin (A, C & E) to determine the granulomatous response.  
Sections B and D indicate iNOS-positive activated macrophages.  Micrographs represent 4 animals/group 



















Breakdown in protective cytokine induction in Tm-TNF mice during late stages of M. 
tuberculosis reactivation.   
Next we assessed immune responses in infected mice prior to and subsequent to INH-RIF 
treatment.  IFNγ and IL-12 levels were quantified because of the reported functions they 
have in generating and maintaining protective immunity against M. tuberculosis 
infection.  Shown in Fig. 3.1A, IL-12p40 levels were comparable in all the strains 21 
days post-infection.  After exposure to INH-RIF treatment, although not significant, an 
elevation of IL-12p40 was observed in TNF-/- mice compared to WT mice quantified at 
day 77 post-infection.  Tm-TNF mice displayed a decreasing trend in IL-12p40 levels 
that were comparable to that of WT mice at day 77 post-infection (Fig. 3.1A).  There was 
no significant difference observed in the expression level of IL-12p70 although there was 
a decreasing trend in TNF-/- mice and Tm-TNF mice compared to WT mice 21 days post-
infection (Fig. 3.1B).  No IL-12p70 could be detected in all the strains at day 77 post-
infection (Fig. 3.1B).  IFNγ was found to be significantly higher (p < 0.01) in TNF-/- mice 
compared to WT mice 21 days post-infection (Fig. 3.1C).  In contrast, Tm-TNF mice 
showed IFNγ levels comparable to WT mice 21 days post-infection (Fig. 3.1C).  No 
differences were observed 77 days post-infection in IFNγ levels in all the strains (Fig. 
3.1C).  Next we quantified the levels of immunoregulatory cytokine, IL-10.  Results 
obtained showed that IL-10 production was slightly higher in TNF-/- mice compared to 
WT mice 21 days post-infection but was statistically insignificant, whereas, in Tm-TNF 
mice the IL-10 values were found to be comparable to that of WT mice (Fig. 3.1D).  The 
concentration of IL-10 measured 77 days post-infection did not vary in all the strains 












WT mice with respect to pulmonary expression levels of cytokines investigated and the 
elevated IFNγ in absence of total TNF after acute M. tuberculosis infection correlate with 
excessive inflammation observed in these mice.  And, the reduced cytokines expression 
levels post INH-RIF treatment is associated with reduced bacilli burdens with exception 
to IL-12p40 in TNF deficient mice which correlates with excess inflammation. 
 
Studies by Feng et al., (2005), demonstrated that continuous IL-12 production is 
necessary for maintenance of pulmonary IFNγ-producing effector CD4+ T cells and 
subsequent bacilli control during chronic M. tuberculosis infection suggesting that 
interruption of IL-12 signal transduction contribute to development of reactivation of 
tuberculosis.  Therefore, we quantified pulmonary IL-12 and IFNγ production during 
tuberculosis reactivation.  Results obtained showed comparable amounts of IL-12p40 
(Fig. 3.2A), IL-12p70 (Fig. 3.2B), and IFNγ (Fig. 3.3C) in both WT mice and Tm-TNF 
mice assessed 133 days post-infection.  However, there was a significant decrease in IL-
12p70 (p < 0.01) and IFNγ (p < 0.05) production in Tm-TNF compared to WT mice 322 
days post-infection (Fig. 3.2B & C, respectively) which associated with susceptibility of 
Tm-TNF mice to M. tuberculosis reactivation at this time point.  IL-12p40 production 
was maintained to be equivalent levels in both strains 322 days post-infection (Fig. 3.2A).  
The concentration of anti-inflammatory IL-10 was found to be comparable measured 133 
days post-infection but increased in WT mice by day 322 post-infection and remained 
significantly lower (p < 0.05) in Tm-TNF mice.  These data suggest that Tm-TNF is not 
enough to sustain protective cytokine induction in post-infection M. tuberculosis 



































Figure 3.1.  Decreasing trend of pulmonary cytokine production with exception to IL-12p40 correlates 
with reduced bacterial burdens after antibiotic treatment.  WT (black bars), TNF-/- mice (white bars) and 
Tm-TNF mice (striped bars) were exposed by aerosol infection to 100 CFU M. tuberculosis H37Rv strain 
for 3 weeks then treated with 25 mg/Kg INH and 25 mg/kg RIF for 6 weeks in drinking water.  
Bronchoalveolar lavage was performed 21 days and 77 days post-infection and the level of IL-12 p40, IL-
12p70, IFNᵧ and IL-10 present in the fluid was determined by ELISA.  Data represent 1 of 2 similar 
experiments and values are expressed as mean ± SD of 5 animals/group.  Significant differences (*p < 0.05; 

























































































































Figure 3.2.  Decrease in pulmonary cytokine production is associated with increased susceptibility 
observed in Tm-TNF mice during M. tuberculosis reactivation.  WT (black bars) and Tm-TNF mice 
(striped bars) were exposed by aerosol inhalation to 100 CFUs/mouse M. tuberculosis H37Rv for 3 weeks 
preceding chemotherapy with 25 mg/Kg INH and 25 mg/kg RIF for 6 weeks in drinking water.  Lungs 
were obtained 133 days and 322 days post-infection and the level of IL-12 p40, IL-12p70, IFNᵧ and IL-10 
present in the homogenates was determined by ELISA.  Data represent 1 of 2 experiments performed and 
values are expressed as mean ± SD of 5 animals/group.  Significant differences (*p < 0.05; **p < 0.01, ns: 



















































































































It has been established that TNF signaling is vital for control of mycobacterial infections 
(Bean et al., 1999; Botha and Ryffel, 2003; Flynn et al., 1995; Jacobs et al., 2000b; 
Kindler et al., 1989).  Specifically, TNF signaling through the p55TNFR (Flynn et al., 
1995), was shown to be important in protective immune responses in mycobacterial 
infections rather than p75TNFR signaling (Jacobs et al., 2000).  In another study, 
challenging TNF-/- mice with recombinant BCG expressing TNF reconstituted granuloma 
structure formation and immune responses but this was not observed in p55TNFR 
deficient mice, supporting the critical role of TNF-p55TNFR signaling in mycobacterial 
specific immunity (Bekker et al., 2001).   
In this study, we investigated the contribution(s) made by the two molecular forms of 
TNF: solTNF and Tm-TNF in generating protective immunity or immunopathology in 
different phases of M. tuberculosis infection.  We used a genetically manipulated knock-
in mouse model where the endogenous TNF allele was replaced with a non-sheddable 
cell surface TNF molecule that is under normal expression and regulation with 
functionality equivalent to its WT counterpart but is resistant to TACE mediated cleavage 
(Ruuls et al., 2001).  Our data confirm that complete absence of TNF results in rapid 
weight loss, unrestricted mycobacterial replication in the lungs and spleens and death 
with a mean survival time of 44 days after challenge with M. tuberculosis H37Rv.  In 
contrast, we show that Tm-TNF is sufficient to induce protective immune responses, 
reflected by the ability of Tm-TNF mice to control mycobacterial growth and 
maintenance of body weight in a manner similar to WT control mice.  Tm-TNF however, 












burdens and death in contrast to WT mice and these observations are supported by 
previous reports (Fremond et al., 2005; Saunders et al., 2005).  Moreover, our data 
illustrate that TNF is important for control of recrudescence of M. tuberculosis infection.  
We found that in our drug-induced tuberculosis reactivation model; although there was 
some degree of inhibition of bacterial replication relative to bacterial replication rate 
observed during the primary infection, the immune response mounted in TNF-/- mice was 
insufficient to inhibit propagation of mycobacteria after cessation of antibiotic treatment.  
This observation confirmed previous findings by Botha and Ryffel (2003), and support 
previous findings showing that treatment of chronically infected mice (Mohan et al., 
2001) or latently infected humans (Dimakou et al., 2004) with TNF neutralizing 
antibodies results in reappearance of tuberculosis.  By contrast, in Tm-TNF mice, 
mycobacterial replication progressed slowly during tuberculosis reactivation in 
comparison to primary infection and this rate was comparable to that observed in WT 
mice indicating that at least in the context of bacilli control, antigen specific effector 
memory responses mounted were equivalent in both strains.  However, Tm-TNF was 
observed to be insufficient for control of long term mycobacterial containment 
resembling the outcome of chronic infection.  Together, these observations demonstrate 
that Tm-TNF can elicit mycobacteria-specific recall responses that are able to suppress 
re-emergence of M. tuberculosis infection but there is a requirement of solTNF for 
maintenance of immune pressure during persistent infection.   
Granuloma formation is an underlying characteristic feature of protective immunity and 
its absence is usually associated with mycobacterial dissemination and lethality (Bean et 












requires cell migration to sites of infection and is associated with TNF dependent 
chemokine induction and regulation of adhesion molecule expression (Hickey et al., 
1997; Mulligan et al., 1993; Roach et al., 2002).  Previous studies described disruptive 
granuloma formation or delayed of granuloma initiation in the absence of TNF signaling 
(Bean et al., 1999; Flynn et al., 1995; Jacobs et al., 2000b).  We show that Tm-TNF 
supports early granuloma formation during attenuated and virulent mycobacterial 
challenge (Dambuza et al., 2008).  However it is clear from comparative bacterial 
burdens in WT mice and Tm-TNF mice that granulomas established in the presence of 
Tm-TNF only, are inferior in bactericidal potential.  This is evident from the onset after 
M. bovis BCG infection and becomes apparent during chronic infection after M. 
tuberculosis challenge.  Interestingly, in contrast to the abnormal pulmonary 
inflammation of CD4+ T cells and CD8+ T cells observed in the absence of total TNF 
during M. bovis BCG infection (Dambuza et al., 2008), enhanced recruitment of both 
lymphocytic subsets were stimulated by Tm-TNF also supported by previous reports 
(Fremond et al., 2005; Saunders et al., 2005).  This may imply that solTNF has an 
inhibitory function during inflammation and that the two molecular forms have distinct 
roles during mycobacterial infection.  The observation during attenuated M. bovis BCG 
challenge is supported by our findings during virulent M. tuberculosis challenge.  In the 
latter case, our data demonstrate the absence of solTNF is characterized by enhanced 
inflammation during persistent infection and leads to formation of large granulomas that 
occupy larger areas of the lung tissue.  Previously Zganiacz et al., (2004), proposed that 
TNF is a negative regulator of Th1-type inflammatory responses and found enhanced 












infection.  In addition to their observations, we propose that Tm-TNF has a cellular 
recruitment function and that solTNF has an important role in mediating inhibitory 
responses during Th1-type inflammation and this holds true for chronic infection and 
drug-induced reactivation tuberculosis.  In other studies, clinical relevance of Tm-TNF 
function in cellular recruitment has been illustrated through its ability to induce 
inflammation and contributing to chronic arthritis (Georgopoulos et al., 1996) and EAE 
(Ruuls et al., 2001).  The concept of different functions of the molecular forms of TNF is 
not unprecedented.  Separate functions for Tm-TNF and solTNF were also described by 
Birkland et al., (1992), who showed that solTNF and membrane TNF expressed on CD4+ 
T cells differentially activates anti-leishmanial mechanisms in macrophages.  
Furthermore, additional studies found that cells insensitive to lysis by solTNF can be 
killed by Tm-TNF (Peck et al., 1989), and growth of retrovirally transduced tumours was 
inhibited by solTNF but not Tm-TNF (Karp et al., 1992).    
IFN is essential for mediating Th1 protective immunity against mycobacterial infections 
(Cooper et al., 1993; Flynn et al., 1993), but in the absence of TNF does not afford 
protection during mycobacterial infections.  In contrast, excessive levels of IFN promote 
tissue necrosis leading to host lethality (Zganiacz et al., 2004).  In this study we found 
significantly higher pulmonary IFN production during late stage infection in TNF-/- mice 
challenged with M. tuberculosis.  Although WT mice and Tm-TNF mice produced 
similar levels of pulmonary IFN during early infection, chronic M. tuberculosis infection 
was associated with significantly higher production of IFNγ in Tm-TNF mice.  We 
therefore propose that Tm-TNF is capable of regulating type 1 immune responses during 












infection to control onset of IFN mediated pathology.  In addition, we found that during 
early stages of tuberculosis reactivation, the levels of IFN were comparable between 
Tm-TNF mice and WT mice supporting further the notion that the emerging 
mycobacteria-specific immune responses are equivalent between the two strains.  
However, a different scenario was observed at later stages of disease reactivation, in 
which we found that relative to WT control, Tm-TNF mice displayed a decline in IFNγ 
levels.  In this context, we suggest that the mechanisms that govern protection collapse 
during tuberculosis reactivation and may involve reduced macrophage-T lymphocyte 
contact required in the case of Tm-TNF to induce a signal.    
With regards to activation of macrophages, IFN-mediated signal during infection results 
in pathogen control.  However uncontrolled IFN production can cause detrimental 
effects and contribute to tissue damage (Parfrey et al., 1999; Zganiacz et al., 2004).  
Similarly, sustained macrophage activation, characterized by increased MHC Class II 
expression has been associated with promoting tissue injury (Huang et al., 2000).  We 
found that in contrast to WT mice, TNF-/- mice displayed increased macrophage 
activation characterized by enhanced surface expression levels of MHC Class II, CD80 
and CD86 on recruited pulmonary CD11b+ cells.  This was further demonstrated by 
increased pulmonary IL-12p70 levels.  Furthermore, there was an increased frequency of 
CD4+ T cells with an enhance activation phenotype reflected by enhanced cell surface 
expression of CD44 which associated with elevated levels of pulmonary IFNγ in TNF-/- 
mice.  It was interesting to note that a similar phenotype is observed in Tm-TNF mice 
during chronic M. tuberculosis infection closer to their death.  It is therefore plausible 












tissue injury.  solTNF may therefore have an inhibitory function in regulating 
macrophage activation during persistent M. tuberculosis infection.  In fact, Watanabe and 
Jacob (1991) found that TNF antagonizes IFN mediated upregulation of MHC class II 
on macrophages in vivo.  Furthermore, we found enhanced levels of iNOS expression 
present in lungs of M. tuberculosis infected Tm-TNF mice which may have contributed 
to local tissue necrosis.  This is supported by findings which demonstrated that BCG 
induced iNOS expression promoted tissue damage whereas iNOS-/- mice were protected 
(Guler et al., 2004). 
Studies have illustrated that both TNF and IL-12 are required to mediate protective 
immunity in part through maintaining the structural integrity of granulomas to limit 
spread of bacilli (Bean et al., 1999; Cooper et al., 1997; Ehlers et al., 2000; Wakeham et 
al., 1998).  In the absence of either cytokines, structural integrity is compromised during 
mycobacterial challenge.  Similarly, both cytokines are required to control infection 
during persistent infection (Botha and Ryffel, 2003; Feng et al., 2005; Mohan et al., 
2001).  In this context, we investigated expression of both IL-12p70 and IL-12p40 during 
tuberculosis reactivation.  Our data show relative to WT control mice, there was 
significant reduction of pulmonary IL-12p70 and not IL-12p40 levels in Tm-TNF mice 
during M. tuberculosis reactivation closer to their demise.  Our results are interesting in 
view of recent data which showed that M. bovis BCG infection reduces IL-12 production 
from host cells (Gagliardi et al., 2005), and suggest that solTNF may regulate IL-12 
production in vivo.  Here we propose that collapse of protective immunity in Tm-TNF 
mice during late phase reactivation is possibly due to reduced cell-cell contact required in 












partly associated with enlarged granulomatous response that does not allow for sufficient 
macrophage-T cell interactions leading to decreased IL-12p70-dependent IFNγ 
production. 
It is interesting to speculate on M. tuberculosis virulence factors that compromise Tm-
TNF mediated immunity.  Genes encoded within the RD1 are obvious candidates because 
of their absence from all M. bovis BCG strains.  ESAT-6 and CFP-10 are located within 
RD1 and have been implicated in regulating immune responses.  Studies supporting this 
suggestion demonstrated that deletion of RD1 from M. tuberculosis H37Rv significantly 
attenuated virulence to assume growth characteristics and granuloma induction potential 
analogous to that of M. bovis BCG (Lewis et al., 2003).  Similarly, reintroduction of RD1 
into M. bovis BCG restored virulence and pathogenicity to rival that of M. tuberculosis 
H37Rv (Majlessi et al., 2005).  It is therefore likely that genes encoded within RD1 may 
have contributed to mycobacterial virulence that resulted in compromised immunity and 
eventual lethality in Tm-TNF mice during pathogenic challenge. 
IL-10 is an inhibitory cytokine required to regulate inflammation in several infectious 
diseases resulting in improved pathogen control (Moore et al., 2001).  Previously, studies 
found enhanced mycobacterial clearance in the absence of IL-10 whereas a limited or no 
role for IL-10 was also described (Jacobs et al., 2000a; North, 1998; Roach et al., 2001).  
In this study we found enhanced IL-10 production associated with end stage disease in 
TNF-/- mice relative to WT mice and Tm-TNF mice during acute M. tuberculosis 
challenge.  Similarly, we found enhanced pulmonary IL-10 production in Tm-TNF mice 
during persistent M. tuberculosis infection.  We therefore propose that increased IL-10 












of TNF and likewise support bacterial persistence in the absence of solTNF during 
chronic infection.  However, our data demonstrates further that low pulmonary IL-10 
levels were not beneficial with respect to M. tuberculosis reactivation as observed for 
Tm-TNF mice.  In this context, our findings contradict studies of Turner et al., (2002), 
who showed that overexpression of IL-10 in chronically but not acutely infected 
C57BL/6 mice resulted in reactivation of disease.  Interestingly, these authors also found 
that susceptibility of mice was associated with reduced IL-12 and TNF levels.  We 
suggest here, that during M. tuberculosis reactivation, excess pulmonary inflammation 
over longer periods possibly depletes IL-10 by a mechanism presently unknown and Tm-
TNF mice eventually succumb to pathology induced by the vigorous immune responses 
to persistent M. tuberculosis.  
 
 In conclusion, data presented here illustrate that TNF mediated immunity against 
M. tuberculosis infections requires both Tm-TNF and solTNF.  Tm-TNF protects mice 
against acute M. tuberculosis infection and is adequate to elicit immune pressure during 
tuberculosis reactivation; solTNF is however necessary for the down modulation of the 
Th1 immune responses during M. tuberculosis infections.  The characterization of the 
molecular forms of TNF in disease outcome will inform design of better therapeutic 
interventions for human subjects suffering from TNF-mediated autoinflammatory 
disorders who become susceptible to intracellular pathogens due to administration of the 
currently used anti-TNF therapies i.e. etanercept, infliximab, and adalimumab; these 
biologics block both Tm-TNF and solTNF (Agnholt et al., 2003; Mitoma et al., 2004; 












new approaches of solely targeting the soluble form of TNF while sparing Tm-TNF and it 
was found that mice were protected from the experimental model of arthritis (Spohn et 
al., 2007; Steed et.al., 2003), Parkinson‘s disease (McCoy et al., 2006) and endotoxin-
induced liver inflammation (Olleros et al., 2009) and still retained immunity against M. 






















4Persistent p55TNFR signaling in M. tuberculosis 
























The pleiotropic activities of TNF are mediated by two structurally related but functionally 
distinct type-1-transmembrane receptors, p55TNFR and p75TNFR expressed in most cell 
types (Aggarwal et al., 1985; Smith and Baglioni, 1989; Tsujimoto et al., 1985).  The 
recent generation of a nonsheddable p55TNFR (p55NS) has provided insights into the 
roles played by both the soluble and the membrane-bound p55TNFR in pathogenesis of 
infectious, inflammatory and autoimmune diseases (Xanthoulea et al., 2004).  We 
hypothesized that sustained p55TNFR cell surface expression will lead to enhanced TNF-
p55TNFR interaction resulting in enhanced immune activation.  Here, our data 
demonstrate that persistent p55TNFR cell surface expression does not afford better 
protection to M. tuberculosis infection, reflected by comparable containment of bacilli 
replication and mortality rates.  We observed a transient elevation in the frequency of 
pulmonary CD11b+/MHC-II+ cells in p55∆NS mice relative to WT mice and comparable 
lung recruitment of CD4+ T cells in both strains but CD44 cell surface expression was 
reduced in p55∆NS mice compared to WT mice.  We also show that pulmonary IL-12p70 
and TNF concentrations were elevated whereas IFNγ levels were reduced in p55∆NS mice 
relative to WT mice.  Furthermore, we propose that enhanced p75TNFR release in p55∆NS 
mice limit TNF signaling.  We demonstrate using a double mutant mouse strain that in 
the absence of p75TNFR, p55∆NS mice controlled bacterial replication better that WT 
















Sustained p55TNFR surface expression in p55∆NS peritoneal elicited cells after M. 
tuberculosis infection.  
The literature is replete with studies that demonstrate loss of TNFRs after infection or 
immunization in vitro and in vivo.  TNFR cleavage from the surface coincides with the 
generation of TNF and its functional significance has been associated with the regulation 
of TNF mediated effects (Engelmann et al., 1989; Engelmann et al., 1990a; Engelmann et 
al., 1990b; Olsson et al., 1989).  Studies by Xanthoulea et al., (2004), showed that upon 
activation with PMA, peritoneal exudate cells derived from p55∆NS mice expressed a 
nonsheddable p55TNFR.  Here we investigated the relationship of p55TNFR expression 
and M. tuberculosis infection.  Thioglycollate elicited macrophages from WT mice or 
p55∆NS mice were exposed to M. tuberculosis H37Rv for 20 minutes and p55TNFR cell 
surface expression was determined by flow cytometry.  p55TNFR cell surface expression 
was detected in both the WT and p55∆NS unstimulated macrophages (Fig. 1.1).  However, 
exposure to M. tuberculosis H37Rv resulted in loss of p55TNFR surface expression on 
WT macrophages (reflected by reduced Mean Fluorescent Intensity) compared to the 
elevated and sustained expression noted in p55∆NS macrophages (Fig. 1.1).  This 
experiment investigated cleavage, as opposed to internalization of p55TNFR; hence 
soluble p55TNFR accumulation in the supernatants of WT and p55∆NS cultures was 
quantified by ELISA.  Detectable levels of soluble p55TNFR were present in 
unstimulated culture supernatants of thioglycollate elicited macrophages from WT mice, 
which increased significantly (p < 0.01) after LPS (Fig. 1.2A) or viable M. tuberculosis 












p55∆NS macrophages before or after stimulation (Fig. 1.2).  These data show that in vitro, 



















































Figure 1.1.  Sustained p55TNFR cell surface expression in p55∆NS cells.  Thioglycollate elicited 
peritoneal macrophages from p55∆NS and WT were stained with anti-p55TNFR before stimulation (black 
histogram) or after 20 min stimulation with M. tuberculosis H37Rv (MOI = 2:1) and analyzed by flow 
cytometry to determine p55TNFR cell surface expression (red histogram, loss in Mean Fluorescent 





































Figure 1.2.  Activation induced soluble p55TNFR cleavage in WT but not p55∆NS cells.  Thioglycollate 
elicited peritoneal macrophages were isolated from WT mice (black squares represent resting cells and 
black circles represent stimulated cells)  and p55∆NS mice (white squares represent resting cells and white 
circles show stimulated cells) and stimulated with 100 ng/ml LPS (A) or M. tuberculosis H37Rv (MOI = 
2:1) (B).  Soluble p55TNFR accumulation in the supernatants was measured at time points indicated above 
by ELISA.  Data are expressed as mean ± SD of 5x105 cells/well performed in triplicates and results are 
representative of 1 of 2 experiments performed.  
 
 


















































Sustained expression of surface p55TNFR does not enhance mycobactericidal 
response. 
The abrogation of TNF-p55TNFR signaling either genetically or with neutralizing 
antibodies has been reported to result in susceptibility to mycobacterial and other 
intracellular infections (Bean et al., 1999; Bekker et al., 2001; Flynn et al., 1995; Kindler 
et al., 1989).  However, dysfunctional TNF regulation has also been reported to have a 
central role in pathogenesis of autoimmune disorders such as rheumatoid arthritis and 
Crohn‘s disease (Dimakou et al., 2004).  The specific functions attributable to soluble and 
membrane TNFRs in various infections and disease states is still not fully understood.  In 
both mice and humans, interference of the shedding of p55TNFR showed enhanced 
sensitivity to TNF mediated immunopathology (Jesus et al., 2008).  Xanthoulea et al., 
(2004), reported enhanced innate immune activation in p55∆NS mice, which mediated 
increased resistance to L. monocytogenes infection in vivo and suggested that persistently 
expressed membrane p55TNFR conferred enhanced protective antibacterial immunity.  In 
consideration of these results, we addressed the in vivo functional role of membrane 
bound p55TNFR and receptor shedding during M. tuberculosis H37Rv infection.  WT 
mice and p55∆NS mice were exposed to a low dose aerosol inhalation infection of 100 
CFUs/mouse M. tuberculosis H37Rv and pulmonary bacilli numbers as well as the extent 
of extra pulmonary dissemination were assessed.  Results obtained showed that p55∆NS 
mice controlled acute phase infection with comparable kinetics to WT mice reflected by 
equivalent bacilli numbers in the lungs (Fig. 2.1A), spleens (Fig. 2.1B) and livers (Fig. 













To determine the effect of sustained p55TNFR expression on disease outcome during 
chronic infection, infected p55∆NS mice and WT mice were monitored for > 500 days.  
Bacilli numbers were maintained at equivalent levels in both strains in the lungs (Fig. 
2.2A) and spleens (Fig. 2.2B) at every time point investigated.  Mortality rates between 
both strains were also found to be comparable (Fig. 2.2C).  These data indicate that 
persistent p55TNFR surface expression does not result in enhanced effector anti-



























































Figure 2.1.  Persistent membrane p55TNFR expression does not enhance control of mycobacterial 
replication.  WT mice (black circles) and p55∆NS mice (white circles) were challenged by aerosol inhalation 
with 100 CFUs/mouse with M. tuberculosis H37Rv.  Bacilli numbers were enumerated in the lungs (A), 
spleens (B) and livers (C) at time points indicated above.  Data are representative of 3 similar experiments 





















































































Figure 2.2.  Control of M. tuberculosis replication is equivalent in p55ΔNS mice and WT mice during 
chronic infection.  WT mice (black circles) and p55∆NS mice (white circles) were challenged by aerosol 
inhalation with 100 CFUs/mouse M. tuberculosis H37Rv.  Bacilli numbers in the lungs (A) and spleens (B) 
were enumerated at time points indicated.  Data are expressed as mean ± SD of 3- 4 animals/group.  (C) 
Mortality rates were monitored over the infection period (n =11).  Results represent 1 of 2 similar 






























































Transient enhanced CD11b cell recruitment to the lung in p55∆NS infected mice. 
To understand how persistent membrane p55TNFR expression affects macrophage 
function in vivo, CD11b+ cell recruitment to the lung and activation state of the cells was 
assessed in WT mice and p55ΔNS mice after M. tuberculosis H37Rv infection.  Single 
cells suspensions were generated from whole lungs and stained for CD11b, MCH-II or 
CD80 expression.  Figure 3A shows that the total cell counts were moderately higher in 
p55∆NS mice compared to WT mice 14 days post-infection.  However, 21 days later, cell 
numbers in WT mice increased at least two fold in contrast to p55∆NS mice which 
remained significantly low (p < 0.05) (Fig. 3A).  These results suggest that persistent cell 
surface p55TNFR expression may negatively regulate cellular migration into the lung. 
 
Flow cytometric analyses of pulmonary cells revealed that there was a significant 
increase (p < 0.01) in the frequency of CD11b+ cells in p55∆NS compared to WT mice at 
day 14 post-infection which increased to equivalent levels in both strains by day 21 post-
infection (Fig. 3B).  We then analyzed the percentage of a subpopulation of CD11b+ cells 
that expressed the MHC-II molecule.  p55ΔNS mice displayed  a significantly higher (p < 
0.05)  CD11b+/MHC-II+ frequency compared to the WT mice 14 days post-infection but, 
by 21 days post-infection, both groups had comparable increased levels of infiltrating 
CD11b+/MHC-II+ cells (Fig. 3C).  The analysis of cell surface expression of MHC-II 
gated on CD11b+ cells was found to be equivalent in both strains at 14 days and 21 days 
post-infection (Fig. 3D).  The expression of co-stimulatory molecule CD80 gated on 
CD11b+ cells was also analyzed and was found to be equivalent in both strains at 14 days 












p55TNFR expression facilitates an increased but transient recruitment of CD11b+/MCH-
II+ cells in vivo but does not enhance the expression levels of MHC-II and CD80 
molecules.  Nonetheless, we postulated that the increased frequency of CD11b+/MHC-II+ 
cells in p55ΔNS mice might drive enhanced M. tuberculosis H37Rv specific type 1 
immune response.  Therefore in view of this, the influx and activation state of CD4+ T 
cells in the lungs of infected WT mice and p55ΔNS mice was then evaluated.  The 
frequency of CD4+ T cells in both strains was found to be equivalent  analyzed at 14 days 
and 21 days post-infection (Fig. 4A).  In addition, the frequency of CD4+/CD44+ T cells 
was also found to be comparable in both strains determined 14 days and 21 days post-
infection (Fig. 4B).  Interestingly, the cell surface expression of CD44 gated on CD4+ T 
cells was found to be significantly lower (p < 0.05) in p55ΔNS mice compared to WT mice 
at day 14 post-infection and increased in both strains by day 21 post-infection, but the 
expression was lower in p55∆NS mice relative to WT mice with no statistical difference 
attained (Fig. 4C).  These data illustrate that despite the comparable CD4+ T cell 
recruitment to lung of WT mice and p55∆NS mice, persistent p55TNFR expression in 





































Figure 3.  Transient elevation of CD11b+/MHC-II+ cells in the lungs of p55ΔNS mice compared to WT 
controls.  WT mice (black bars) and p55∆NS mice (white bars) were infected by aerosol inhalation with 100 
CFUs/mouse M. tuberculosis H37Rv.  (A) Lung single cell were generated at day 14 and day 21 post-
infection and stained for CD11b, MHC-II or CD80 then analyzed by flow cytometry.  Percentages of 
CD11b+ (B) and CD11b+/MHC-II+ (C) cells in the lung and MFIs of cell surface expression of MHC-II (D) 
and CD80 (E) gated on CD11b+ cells.  Data are representative of 1 of 3 experiments performed and results 
are expressed as mean ± SD from 4 mice/group.  Significant differences (*p < 0.05; **p < 0.01) were 



































































































































Figure 4.  Persistent membrane p55TNFR expression does not improve CD4 + T cell recruitment into the 
lung but CD4+ T cell activation is reduced.  WT mice (black bars) and p55∆NS mice (white bars) were 
infected by aerosol inhalation with 100 CFUs/mouse M. tuberculosis H37Rv.  Single cell suspensions were 
generated from lung tissue at day 14 and day 21 post-infection and cells were stained with anti-CD4 and 
anti-CD44.  (A) Percentages of CD4+ T cells and CD4+/CD44+ T cells (B) as well MFIs of cell surface 
expression of CD44 (C) gated on CD4+ T cells were analyzed by flow cytometry.  Data represent 1 of 3 
experiments performed and results are expressed as mean ± SD of 4 mice/group.  Statistical difference (*p 





































































Persistent p55TNFR expression has varying effects on macrophage and T lymphocyte 
function in acute M. tuberculosis H37Rv-infected mice. 
IL-12p70, TNF and IFNγ are known critical mediators of anti-mycobacterial immunity 
(Cooper et al., 1993; Cooper et al., 1997; Feng et al., 2005; Flynn et al., 1993; Frankova 
and Zidek, 1998).  To determine the influence of persistent p55TNFR expression on 
cytokine production, lungs from M. tuberculosis H37Rv infected WT mice and p55∆NS 
mice were obtained at specific time points and the concentration of cytokines was 
measured by ELISA.  The concentration of IL-12p70 in p55∆NS mice was higher at 14 
days and 21 days post-infection but was not statistically different from WT mice 
declining to equivalent levels in both strains by day 28 post-infection (Fig. 5A).  
Although TNF levels were equivalent at day 14 post-infection for both strains, higher 
concentrations were subsequently measured at day 21 and day 28 post-infection in p55∆NS 
mice with significant difference at day 21 (p < 0.05) (Fig. 5B).  These data suggest that 
macrophage activation at least with respect to IL-12p70 production is moderately 
enhanced in p55∆NS mice relative to WT mice. 
 
An inverse trend was observed when comparing the kinetics of IFNγ production.  p55∆NS 
mice displayed lower concentrations with significant differences observed at day 21 (p < 
0.05) and day 28 (p < 0.01) post-infection (Fig. 5C) compared to WT mice.  Next, we 
analyzed the levels of the immunoregulatory cytokine, IL-10.  Here, WT mice and p55∆NS 
mice showed comparable IL-10 concentrations at all the time points investigated (Fig. 
5D).  Together, these data suggest that persistent p55TNFR expression is associated with 







































Figure 5.  Enhanced pulmonary TNF and IL-12p70 but reduced IFNγ production in p55∆NS mice.  WT 
mice (black circles) and p55∆NS mice (white circles) were infected by aerosol inhalation with 100 
CFUs/mouse M. tuberculosis H37Rv.  Lungs were isolated and homogenized at time points indicated and 
the levels of IL-12p70 (A), TNF (B), IFNγ (C) and IL-10 (D) were quantified by ELISA.  Data are 
representative of 1 of 3 experiments performed and the results are expressed as mean ± SD from 4 mice/ 


















































































We next analyzed memory antigen-specific T cell IFNγ induction in WT mice and p55∆NS 
mice.  Whole mediastinal lymph node cells were isolated 28 days post-infection and 
single cell suspensions were generated then restimulated with either viable M. 
tuberculosis H37Rv, or mycobacteria-specific ESAT-6.  Depicted in Fig. 6, the 
concentration of IFNγ was found to be equivalent in both strains after 72 h restimulation 
with M. tuberculosis H37Rv or ESAT.  TCR/CD3 ligation of T cells with anti-CD3 and 
co-stimulatory anti-CD28 resulted in comparable IFNγ levels in both strains (Fig. 6).  
These data suggest that in vivo, lymphocyte antigen-specific memory responses are not 





















































Figure 6.  Assessment of T cell IFNγ antigen-specific recall responses in p55ΔNS.  WT mice (black bars) 
and p55∆NS mice (white bars) were infected by aerosol inhalation with 100 CFUs/mouse M. tuberculosis 
H37Rv and whole mediastinal lymph nodes cells were isolated 28 days post-infection and restimulated 
with either viable M. tuberculosis H37Rv (MOI = 2:1) or 5 µg/ml anti-CD3/anti-CD28 or 10 µg/ml ESAT-
6 for 72 h, and IFNγ concentration was quantified in the supernatants by ELISA.  Results are representative 














































































Persistent membrane p55TNFR expression is associated with enhanced production of 
pro-inflammatory mediators from macrophages in vitro. 
We hypothesized that the inability to shed p55TNFR might result in enhanced TNF 
signaling.  Results obtained from our in vivo studies showing that M. tuberculosis H37Rv 
bacilli growth was controlled in p55ΔNS mice in a manner similar to WT mice (Fig. 2.1 & 
2.2) were therefore interesting and warranted further investigation.  To determine how 
sustained membrane p55TNFR expression influences macrophage activation, 
macrophages from WT mice and p55∆NS mice were prestimulated with equimolar IFNγ 
concentrations for 4 h and TNF and nitric oxide (NO) levels were quantified following 
stimulation with LPS or M. tuberculosis H37Rv.  Consistent with published data 
(Xanthoulea et al., 2004), stimulating p55∆NS  derived macrophages with 100 ng/ml LPS 
resulted in increased TNF concentration in a time dependent manner with a significant 
difference (p < 0.05) observed at 300 min compared to WT derived macrophages (Fig. 
7.1A).  A similar result was obtained when macrophages were challenged with M. 
tuberculosis H37Rv, however, TNF concentrations were found to be 10 fold less when 
compared to LPS stimulation (Fig. 7.1B).  These data suggest that persistent p55TNFR 
expression positively enhance macrophage TNF production during LPS or M. 
tuberculosis stimulation. 
 
Previous studies have established that TNF and IFNγ synergize to optimally activate 
macrophages to produce the effector molecule Nitric Oxide (NO) for mycobacterial 
killing (Ding et al., 1988; Flesch and Kaufmann, 1990).  Therefore, we quantified the 












was significantly enhanced (p < 0.05) in p55∆NS derived macrophages relative to WT 
controls after 48 hours stimulation with LPS (Fig. 7C).  Similar results were attained 
when macrophages were stimulated with M. tuberculosis H37Rv, with significant NO 
increase (p < 0.001) observed as early as 24 h after stimulation and a further increase in 
NO synthesis (p < 0.05) was observed 48 h after stimulation in p55∆NS mice compared to 
WT mice (Fig. 7D).  Therefore, the increased synthesis of TNF and NO in p55∆NS 













































Figure 7.1.  Enhanced TNF and Nitric Oxide production in peritoneal exudate cells expressing a non-
sheddable form of p55TNFR.  Bone marrow derived macrophages were isolated from WT mice (black 
circles) and p55∆NS mice (white circles) were prestimulated with 100 U/ml IFNᵧ for 24 h prior stimulation 
with (A & C) 100 ng/ml LPS or (B & D) M. tuberculosis H37Rv,  MOI = 2:1.  The kinetics of soluble TNF 
accumulation in the supernatants was measured by ELISA (A & B), and the production of nitrite 
(pulmonary nitrate produced is reduced by nitrite reductase to nitrite) was quantified using Griess reagent 
(C & D).  Results represent 1 of 3 similar experiments and data are expressed as mean ± SD of 5x105 
cells/well plated in triplicates.  Statistical significance (*p < 0.05; **p < 0.01; ***p < 0.001) was 
determined by Student‘s t test.  
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Elevated levels of soluble p75TNFR in p55ΔNS macrophages: possible limiting factor of 
TNF bioavailability 
Soluble TNFRs are thought to modulate TNF responsiveness.  However, there is 
controversy about the role mediated by these receptors -whether they serve as agonists or 
antagonists of TNF effects.  Nonetheless, both TNFRs are proteolytically cleaved from 
the cell surface in the presence of inflammatory stimuli and the levels of soluble 
p75TNFR greatly exceed those of soluble p55TNFR.  This increased shedding implies a 
more dominant role for p75TNFR in down regulating TNF driven responses (Peschon et 
al., 1998).  To determine whether there is a difference in p75TNFR shedding between 
WT and p55ΔNS derived macrophages, the levels of soluble p75TNFR were quantified in 
the supernatants after cells were stimulated with 100 ng/ml LPS or viable M. tuberculosis 
H37Rv bacilli at MOI of 2:1.  Results obtained showed that p55ΔNS  derived macrophages 
produced significantly higher levels (p < 0.01) of soluble p75TNFR when stimulated with 
either LPS (Fig. 7.2A) or M. tuberculosis H37Rv (Fig. 7.2B) for 300 minutes.  These data 
indicate that defective p55TNFR shedding results in significant increased release of 
soluble p75TNFR as a compensatory mechanism with potential to modulate TNF 
activity.  To determine whether this increased soluble p75TNFR had an effect on TNF 
bioactivity, TNF mediated cytotoxicity was evaluated using WEHI cells.  Interestingly, 
the amount of bioactive TNF was comparable in both strains (Fig. 7.2C).  The results 
therefore indicate that even though there is significantly increased total TNF in p55ΔNS 









































Figure 7.2  Increased soluble p75TNFR correlates with equimolar bioactive TNF in WT and p55∆NS.  
Bone marrow derived macrophages from WT mice (black circles) and p55∆NS mice (white circles) were 
stimulated with 100 ng/ml LPS (A) or M. tuberculosis H37Rv MOI = 2:1 (B) and the levels of soluble 
p75TNFR were quantified by ELISA.  (C) Bioactive TNF was measured by cytotoxicity assay using TNF 
sensitive WEHI cell line.  Data represent 1 of 2 experiments performed and results are expressed as mean ± 








































































p75TNFR deficiency in the presence of persistent p55TNFR expression results in 
improved bacterial clearance. 
We postulated that increased p75TNFR shedding in p55∆NS mice resulted in 
neutralization of TNF bioactivity to levels equivalent to that of WT mice despite the 
higher levels of TNF synthesis observed in this strain.  To test this postulate, we 
investigated immune responses in p55∆NS in the absence of p75TNFR.  We generated a 
double mutant p55∆NS-p75-/- mouse strain for comparative challenge studies.  Here, we 
infected WT mice, p55∆NS mice, p75-/- mice and p55∆NS-p75-/- mice with 100 
CFUs/mouse M. tuberculosis by aerosol inhalation and the lungs and spleens were 
harvested at day 28 post-infection to compare bacilli burdens in the respective mouse 
strains.  Results obtained showed that there was no statistical difference in bacilli burdens 
between WT control mice and p55∆NS mice in the lungs (Fig. 8A) and spleens (Fig. 8B) at 
day 28 post-infection.  Mice deficient for p75TNFR were found to have reduced bacilli 
numbers in the lungs (Fig. 8A) and spleens (Fig. 8B) relative to WT mice at day 28 post-
infection but no statistical difference was attained, in contrast, p55∆NS-p75-/- mice 
displayed a significant reduction in bacilli burdens in the lungs (p < 0.01) and more 
impressively in the spleens (p < 0.01) (Fig. 8A & B, respectively).  These data indicate 
that persistent p55TNFR expression in the absence of p75TNFR mediate an enhanced 
mycobactericidal response in vivo and imply that p75TNFR shedding play a dominant 
role in modulating TNF bioavailability.   
 
We next compared granuloma structure formation in WT mice, p55∆NS mice, p75-/- mice 












differences in granuloma structures that were formed in all the mouse strains investigated 
(Fig. 9.1); in addition, iNOS expression pattern was comparable in all the groups (Fig. 
9.2).  Thus, these results illustrate that p75TNFR is not required for granuloma structure 













































Figure 8.  Absence of p75TNFR in the presence of persistent p55TNFR expression improves 
mycobactericidal responses in vivo.  WT mice (black circles), p55∆NS mice (white circles), p75-/- mice 
(grey circles) and p55∆NS-p75-/- mice (green circles) were infected by aerosol inhalation with 100 
CFUs/mouse M. tuberculosis H37Rv.  Bacilli numbers were enumerated in the lungs (A) and spleens (B) at 
day 28 post-infection.  Data are representative of 1 of 2 experiments and results are expressed as mean ± 
































































































Figure 9.1.  p75TNFR is not required for granuloma structure formation in M. tuberculosis infection..  
WT mice (A), p55∆NS mice (B), p75-/- mice (C) and p55∆NS-p75-/- mice (D) were infected by aerosol 
inhalation with 100 CFUs/mouse M. tuberculosis H37Rv.  Lung sections were removed at day 28 post-
infection and stained with haematoxylin and eosin.  Micrographs are representative of 5mice/group shown 





































Figure 9.2.  iNOS expression is similar in all the strains after M. tuberculosis infection.  WT mice (A), 
p55∆NS mice (B), p75-/- mice (C) and p55∆NS-p75-/- mice (D) were infected by aerosol inhalation with 100 
CFUs/mouse M. tuberculosis H37Rv.  Lung sections were removed at day 28 post-infection and stained 
with polyclonal rabbit anti-mouse antibody (see Materials and methods), the brown stain is indicative of 






















Several studies have shown that TNF mediate protective effects in immunity against 
invading pathogens (Bean et al., 1999; Florido and Appelberg, 2007; Garcia et al., 1997; 
Jacobs et al., 2000b; Kindler et al., 1989; Roach et al., 2002) but is also one the chief 
mediators in pathogenesis of endotoxic shock (Rothstein and Schreiber, 1988) and its 
neutralization with antibodies results in alleviation of autoimmune inflammatory 
disorders such as rheumatoid arthritis and Crohn‘s disease (Dimakou et al., 2004; 
Sichletidis et al., 2006).  The widespread expression of the TNFRs on different cell types 
and tissues reported by several researchers (Aggarwal et al., 1985; Smith and Baglioni, 
1989; Tsujimoto et al., 1985) show that TNF can interact with a vast array of target cells 
and hence TNF-TNFR mediated effects are tightly regulated.  TNF mediated activities 
are regulated by multiple regulatory mechanisms and one important way is thought to be 
proteolytic shedding of TNFRs from cell surfaces resulting in soluble TNFRs that can 
bind TNF thereby competing with cell surface receptors thus limiting TNF function in 
target cells (Engelmann et al., 1989; Engelmann et al., 1990a; Engelmann et al., 1990b; 
Olsson et al., 1989).  However, the in vivo significance of TNFR shedding has remained 
vague.  McDermott et al., (1999), reported that in humans, different missense mutations 
on the p55TNFR gene that associate with defective receptor shedding strongly associate 
with autosomal dominant periodic fever syndromes known as TRAPS which include 
recurrent episodes of fever, myalgia, rash, abdominal pain, conjunctivitis and arthritis and 













In this study, we investigated the functional relevance of persistent p55TNFR cell surface 
expression and p55TNFR shedding during infection with M. tuberculosis H37Rv using a 
mutant mouse strain (p55∆NS) with p55TNFR wild type receptor functionality but have 
defective shedding capability (Xanthoulea et al., 2004).  We show using an in vitro 
macrophage culture system that p55TNFR is released from the cell surface prior to and 
after cell activation with either LPS or viable M. tuberculosis H37Rv bacilli and this 
observation is in agreement with previous reports which also showed in other systems 
that soluble TNFRs are generated after exposure to stimuli (Lantz et al., 1990; 
Leeuwenberg et al., 1994; Porteu and Nathan, 1990).  Moreover, our results show both 
the constitutive and M. tuberculosis-activation induced shedding are inhibited in p55∆NS 
derived cells and this result correlates with the presence of cell surface p55TNFR which 
coincides with previous studies which used PMA to stimulate cells using a similar mutant 
mouse (Xanthoulea et al., 2004) confirming persistency of cell surface receptor 
expression.  
Studies have shown that interference of TNF-p55TNFR signaling pathway either by gene 
deletion of ligand or receptor or by neutralizing antibodies leads to susceptibility to 
mycobacterial and other intracellular pathogens (Bean et al., 1999; Jacobs et al., 2000b; 
Kaneko et al., 1999; Pfeffer et al., 1993; Rothe et al., 1993b) but the characteristic role(s) 
of both soluble p55TNFR and the membrane bound p55TNFR were not clearly defined in 
vivo during challenge with pathogens.  We hypothesized that persistent cell surface 
p55TNFR expression will result in enhanced TNF-p55TNFR interaction leading to 
enhanced immune responses.  Our data demonstrate that persistent cell surface p55TNFR 












in both the acute and chronic phases of the infection.  We found that mice expressing the 
mutant persistent cell surface receptor succumbed to infection with similar kinetics to 
control mice and that bacterial clearance was equivalent in both strains suggesting that 
host bactericidal mechanisms were not improved.  These results were surprising because 
an earlier study by Xanthoulea et al., (2004), showed that challenging p55∆NS mice with 
increasing doses of L. monocytogenes results in improved host resistance in mutant mice 
relative to control animals suggesting that defective p55TNFR shedding enables 
enhanced antibacterial host mechanisms and that pathogens may evoke p55TNFR 
shedding as an immune escape mechanism.   
Nevertheless, we investigated the host immune responses in p55∆NS mice to better 
describe what happens during M. tuberculosis infection.  We found that pulmonary 
cellular recruitment does not increase over the course of infection in p55∆NS mice relative 
to control animals, this outcome was interesting because TNF is known as the master 
orchestrator of all stages of inflammation from recruitment of inflammatory cell, 
limitation of the process to its termination with repair of inflammation induced damage 
through promotion of fibroblast growth (Vilcek et al., 1986) and neovascular formation 
(Frater-Schroder et al., 1987).  Closer inspection of the lung cell populations during early 
infection revealed that there is a transient increase in the frequency of CD11b+/MHC-II+ 
expressing cells in mice persistently expressing p55TNFR but the activation state of these 
cells determined by mean fluorescent intensity of the cell surface expression levels of 
MCH-II and co-stimulatory molecule CD80 is not enhanced compared to WT controls.  
However, by virtue of the observed transient increase of pulmonary CD11b+/MHC-II+ 












role in the generation and activation of Th1 immune responses (Hsieh et al., 1993; 
Oswald et al., 1994), we hypothesized heightened type 1 immune induction in mice 
expressing persistent cell surface p55TNFR.  Other studies have demonstrated 
importance of IL-12 showing that in its absence mice are susceptible to infection with 
mycobacteria and this was associated with impaired type 1 cytokine responses as well as 
malformed granuloma structures (Cooper et al., 1997; Wakeham et al., 1998).  We found 
that persistent p55TNFR expression is associated with a decrease of total pulmonary 
IFNγ levels and this observation correlated with a decrease in CD4+ T cell activation state 
reflected by a decrease in mean fluorescent intensity of CD44 expression on CD4+ T cells 
although the total frequency of pulmonary CD4+ T cells was equivalent in both strains.  
As a possible mechanism known to down regulate Th1 immune responses (Gong et al., 
1996), we investigated the kinetics of pulmonary IL-10 levels and interestingly we found 
equivalent concentrations in both strains, suggesting other mechanisms that modulate 
IFNγ production might be at play.  One such mechanism explores the potent TNF-TNFR 
immunomodulatory effects and has been elegantly demonstrated by Isomaki and 
colleagues (2001), using T cell hybriboma clones which were exposed chronically to 
TNF resulting in down regulation of TCRδ and expression of the TCR/CD3 complex at 
the cell surface and ultimately leading to T cell hyporesponsiveness reflected by decrease 
in antigen-specific proliferation and suppression of cytokine responses.  In addition, the 
authors demonstrate that this T cell hyporesponsiveness is mediated through p55TNFR 
and is TNF dependent as IL-1 which shares some signaling pathways with TNF does not 
induce the suppressive effects on the T cell hybridomas.  Another study by Cope et al., 












mice that persistent p55TNFR signaling leads to down modulation of T cell responses.  
Therefore, the results obtained suggest that persistent p55TNFR expression have different 
outcomes with regards to macrophage and CD4+ T cells activation and this is further 
corroborated by results presented by Xanthoulea et al., (2004), which demonstrate 
macrophage hyperactivation following stimulation with LPS and the authors suggest 
presence of a positive feed-back loop operating between cell surface p55TNFR and TNF 
mRNA transcription and/or stabilization.  These outcomes however, have not been 
demonstrated in M. tuberculosis H37Rv infections. 
It was intriguing though, that the observed reduced levels of IFNγ did not result in less 
resistance to challenge with M. tuberculosis in p55∆NS mice possibly because the IFNγ 
levels were still sufficient to induce protective effects, moreover, we found that cells 
derived from lung draining lymphoid tissue of these mice produced IFNγ similar to WT 
controls after 72 h stimulation with either mycobacteria-specific ESAT-6 antigen, or live 
M. tuberculosis bacilli, or stimulation with anti-CD3/CD28.  Although commonly used, 
this ex-vivo method does not take into account when comparing the different mouse 
strains the number of peptide/MHC complexes on antigen presenting cells or the level of 
costimulatory molecules at the T cell-antigen presenting cell interface which may 
influence the amplitude of the T cell activation and therefore, the results obtained may be 
difficult to interpret (Kupfer, A., and Singer, S.J., 1989; Kupfer et.al.,1989; Wülfing, C., 
and Davis, M.M., 1998; Wülfing et al., 1998). 
Regarding possibilities of TNF-TNFR immunomodulatory effects in our system, we 
focused our attention on TNF neutralizing potential of soluble TNFRs as a way of 












reports have indicated that soluble TNFRs are natural inhibitors of TNF and were shown 
be present in blood and urine (Engelmann et al., 1989; Engelmann et al., 1990b; Novick 
et al., 1989).  Pinckard and colleagues (1997), showed that both the TNFRs are 
constitutively shed in the circulation and their levels increase during the course of 
different disease states (Diez-Ruiz et al., 1995) and after stimulation with TNF (Lantz et 
al., 1990).  More recently, van Mierlo et al., (2008), identified p75TNFR shedding to be a 
novel mechanism by which T regulatory cells down modulates inflammatory mediators.  
Our data show that p55TNFR is released in WT macrophages after stimulation with 
either LPS or viable M. tuberculosis H37Rv bacilli which contradicts the observation 
reported by Balcewicz-Sablinska et al., (1998).  In their in vitro culture system soluble 
p55TNFR levels were not significantly elevated after stimulation of human alveolar 
macrophages with either avirulent M. tuberculosis H37Ra or virulent M. tuberculosis 
H37Rv, however our results do support p55TNFR release shown in other studies (Aderka 
et al., 1991; Carpenter et al., 1995; Pinckard et al., 1997).  Furthermore, we show that 
more p75TNFR is released after macrophage activation with either LPS or viable M. 
tuberculosis H37Rv compared to p55TNFR release, this phenomenon has been reported 
elsewhere (Aderka et al., 1991; Carpenter et al., 1995; Pinckard et al., 1997).  Moreover, 
we show that persistent p55TNFR leads to further release of p75TNFR after macrophage 
stimulation with both stimulants used, LPS or viable M. tuberculosis H37Rv bacilli.  This 
could be explained by the increased TNF levels in macrophages expressing persistent cell 
surface p55TNFR and this result coincides with previous reports (Xanthoulea et al., 
2004) but another possibility is receptor cross-regulation suggested by Higuchi and 












TNF, IL-1 (Joyce and Steer, 1995)and IL-10 (Balcewicz-Sablinska et al., 1998; Joyce et 
al., 1994) were reported to influence release of p75TNFR.  In this context, it appears that 
p75TNFR shedding may be regulated by multiple mechanisms.  In addition, the 
enzymatic regulatory mechanisms that influence metalloprotease TNF-α-converting 
enzyme (Peschon et al., 1998) and carboxy-peptidase cathepsin-D (Coyne et al., 1999) 
established as key players of p75TNFR release need further investigation to determine 
whether their activity during inflammatory processes and infections is affected. 
We demonstrate that the increased p75TNFR expression in p55∆NS macrophages is 
associated with TNF bioactivity that is equivalent to WT control macrophages and we 
associated this with the similar outcome of M. tuberculosis infection in p55∆NS mice and 
WT mice.  Many studies have shown TNF-TNFR complexes and the therapeutic benefits 
for down modulating excess TNF using anti-TNF antibodies or administration of soluble 
TNFRs have been realized as well as the consequences of complete TNF neutralization.  
We investigated genetic deletion of p75TNFR in mice persistently expressing p55TNFR 
to determine whether control of mycobacterial infection is enhanced.  We reasoned that 
the resultant double mutant mouse strain p55∆NS-p75-/- will allow for better TNF-
p55TNFR signaling which should enhance immune responses against M. tuberculosis 
H37Rv and lead to better clearance because of more biologically active TNF.  We found 
that after challenging mice with M. tuberculosis H37Rv, absence of p75TNFR alone 
results in better bacterial control relative to WT control mice and this outcome is slightly 
better than p55∆NS mice.  Our data further demonstrate more significant bacterial control 
is observed in mice expressing persistent p55TNFR in absence of p75TNFR (p55∆NS-p75-












smaller consequently due to reduced bacilli burdens.  It must be noted that p75TNFR is 
redundant with regards to granuloma structure formation because in p75TNFR deficient 
mice the bactericidal granulomas are formed. 
Although we show that p75TNFR shedding controls bioactive TNF levels, our results do 
not exclude the possibility that M. tuberculosis itself use p75TNFR shedding as an 
immune evasion mechanism and this line of thought is supported by Balcewicz-Sablinska 
et al., (1998), showing decrease in macrophages apoptosis after challenge with M. 
tuberculosis and the authors suggest that virulent mycobacterial strains achieve this by 
inducing IL-10-dependent p75TNFR shedding.  
The role of signaling through p75TNFR in host immunity must not be ignored.  To date, 
there is controversy regarding the in vivo functional role of p75TNFR, Allendoerfer and 
Deepe Jr., (2000), show a protective function against infection with fungus such as H. 
capsulatum, where deficiency of p75TNFR leads to reduced IFNγ production and 
treatment with this cytokine restores protective immunity.  Furthermore, infections with 
the intracellular parasite T. brucei result in reduced infection-associated pathology in 
absence of p75TNFR (Magez et al., 2004).  By contrast, Peschon et al., (1998), showed 
that p75TNFR does not play a role in host immunity after L. monocytogenes infection.   
 
 In conclusion, our results confirm previous reports that show that signaling 
through p55TNFR is important for control of M. tuberculosis infection and p75TNFR 
signaling is redundant.  We demonstrate clearly that p55TNFR shedding is subservient to 
p75TNFR shedding in attenuating TNF activities.  Therefore, the enhanced immune 












bioavailability and specific targeting of soluble p75TNFR might be beneficial for 
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General Solutions 
 
All the chemical reagents used were purchased from Merck Laboratory Supplies 
(Germany) or Sigma-Aldrich (St. Loius, USA) unless otherwise stated. 
 
 
Difco Middlebrook 7H10 agar 
19 g of 7H10 agar was dissolved in distilled H2O with 5 ml glycerol and the volume was 
made up to 900 ml with distilled H2O.  The solution was autoclaved at 121°C for 10 
minutes and was allowed to cool to 55°C before adding 100 ml OADC.  Seven miles per 
side was poured on sterile Sterilin duplicate petridishes.  Agar was allowed to solidify at 
room temperature before storage at 4°C. 
 
Formalin  
100 ml formaldehyde (40% w/v) and 
900 ml PBS (pH 7.4) were mixed and stored at room temperature in the dark. 
 
0.9% Saline 
9 g NaCl was dissolved in 
100 ml distilled H2O and autoclaved at 121°C for 30 minutes.  The solution was stored at  
room temperature. 
 
Tween 80 saline 
0.04% Tween 80 and 
0.9% saline was dissolved in distilled H2O and autoclaved at 121°C for 30 minutes.   
The solution was stored at room temperature. 
 
10x PBS 
80 g NaCl, 
2.4 g KH2PO4, 
2 g KCl and 
14.4 g Na2HPO4.2H2O were dissolved in  
900 ml distilled H2O,  
The pH was adjusted to 7.4 with HCl and the volume was made up to 1000 ml with 
distilled  
H2O then sterilized by filtering through a 0.45 µm filter (Millipore Corporation, Bedford, 


















Flow cytometry solutions 
 
10% NaN3 
10 g NaN3 was dissolved in 
100 ml distilled H2O and sterilized by filtration through a 0.45 µm filter (Millipore 




1 g BSA (Boeringer Mannhain, Germany) and 
0.1 g NaN3 were dissolved in 
900 ml 1x PBS. 
The pH was adjusted to 7.4 and the volume was made up to 1000 ml then sterilized 
through using a 0.45 µm filter (Millipore Corporation, Bedford, USA) and stored at 4°C. 
 
FACS blocking buffer 
3.75 µl normal rat serum (heat inactivated), 
3.75 µl normal mouse serum (heat inactivated), and 
0.9375 µl anti-CD32/CD16c (anti-FCγRIII/II) (clone 2.4G2, Pharmingen) were made up 
to 150 µl with FACS buffer. 
 
FACS fixation buffer  
4 g NaOH was dissolved in 
100 ml 1x PBS, 
20 g paraformaldehyde was added, the volume was made up to 1000 ml and the pH was  
adjusted to 7.2.  The solution was sterilized by filtering through 0.45 µm filter (Millipore  
Corporation, Bedford, USA) and stored at 4°C in the dark. 
 
The following antibodies purchased from Pharmingen were used in this study : anti-CD4-
FITC (H129.19), anti-CD11a-PE (M17/4), anti-CD44-PE (IM7), anti-CD86-PE (GL1), 
anti-CD80-PE (16-10A1), anti-CD120b-PE (HM 102), anti-CD62L-PE (MEL-14), anti-
CD69-PE (H1.2F3), anti-I-A/I-E-PE (M5/14.15.2), anti-CD11b-FITC, anti-CD49a-PE, 
anti-IgG 2a-FITC (R35-95), anti-IgG 2a-PE (R35-95) and, anti-IgG-PE (G70-204)  . 
 
 
ELISA solutions and brief protocol 
 
Coating buffer 
0.2 g NaN3 was dissolved in 
800 ml 1x PBS.  The pH was adjusted to 7.2 and the volume was made up to 1000 ml 
then sterilized through filtering using 0.45 µm filter (Millipore Corporation, Bedford, 














10 g BSA (Boeringher Mannheim, Germany) and 
0.3 g NaN3 were dissolved in  
800 ml 1x PBS.  The pH was adjusted to 7.4; the volume was made up to 1000 ml then  
sterilized through filtering using 0.45 µm filter (Millipore Corporation, Bedford, USA) 
and stored at 4°C. 
 
Reagent diluent 
0.1% BSA (Boeringher Mannheim, Germany) and 
0.05% Tween 20 were dissolved in saline containing  
20 mM Trizma base and  
150 mM NaCl.  The pH was adjusted to 7.4 then sterilized through filtering using 0.45 
µm filter (Millipore Corporation, Bedford, USA) and stored at 4°C. 
 
Blocking buffer 1 
1% BSA (Boeringher Mannheim, Germany), 
5% Sucrose and 
0.05% NaN3 were dissolved in 1x PBS, the pH of the solution was adjusted to 7.4 then  
sterilized through filtering using 0.45 µm filter (Millipore Corporation, Bedford, USA) 
and stored at 4°C. 
 
Blocking buffer 2 
40 g BSA (Boeringher Mannheim, Germany), 
0.2 g NaN3 were dissolved in  
800 ml 1x PBS.  The pH was adjusted to 7.4 then sterilized through filtering using 0.45 
µm filter (Millipore Corporation, Bedford, USA) and stored at 4°C. 
 
20x Wash buffer 
20 g KCl, 
20 g KH2PO4, 
144 g NaH2PO4, and  
800 g NaCl were dissolved in 4.5 L of distilled H2O. 
50 ml Tween 20 and 
100 ml 10% NaN3 were added.  The volume was made up to 5 L then sterilized through  




0.2 g NaN3 and 
0.8 g MgCl2 were dissolved in 700 ml distilled H2O, 
97 ml liquefied diethanolamine was added then the volume was made up to 1000 ml.  
The pH was adjusted to 9.8 and the solution was then sterilized through filtering using 

















Supernatants from organ homogenates or from cultured cells were harvested and assayed 
for cytokine concentrations using commercially available ELISA reagents for TNF, IFNγ, 
IL-10, IL-12p40, IL-12p70, p55TNFR and p75TNFR (R&D Systems, Germany and BD 
PharMingen, San Die).  Briefly, Nunc Maxisorp 96 well plates (Nalge Nunc 
International, Naperville, IL, USA) were coated with 50 µl of capture antibody at 2 µg/ml 
except for TNF and IFNγ (coated with 1 µg/ml and 4 µg/ml capture antibody, 
respectively) overnight at 4°C.  Wells were washed with 1x wash buffer and blocked with 
300 µl of block buffer for 1 h at 37°C.  After washing the wells, 50 µl of samples or 50 µl 
appropriate recombinant mouse standards at 2 fold dilutions (diluted in Reagent diluent) 
at a starting concentration of 2 ng/ml except for TNF which was added in 3 fold serial 
dilutions (diluted in dilution buffer) at a starting concentration of 100 ng/ml were 
incubated for 2 h at 37°C.  Wells were washed with 1x wash buffer and 50 µl of 
appropriate biotinylated detection antibody at recommended concentrations were added 
and incubated for 2 h at 37°C.  Wells were washed with 1x wash buffer and incubated in 
50 µl of streptavidin-alkaline phosphatase (R & D Systems, Minneapolis, USA) at 1: 
1000 dilution for at least 45 min at room temperature, for TNF ELISA, wells were 
incubated at 1: 10000 with alkaline phosphatase-labelled goat anti-rabbit (BD 
PharMingen, San Diego, USA) for at least 2 h at room temperature.  Wells were washed 
with 1x wash buffer and 50 µl of p-nitrophenyl phosphate substrate (Boehringher 
Mannheim, Germany) at 1 mg/ml was added, the yellow colour was allowed to develop 
and absorbance was read at 405 nm on a VERSAmax Tunable Microplate Reader 
(Molecular Devices Corporation, California, USA) and for data analysis, SoftMax Pro 
4.3 software (Molecular Devices Corporation, California, USA) was used.     
 
 
Histology reagents and brief protocol 
 
E1 Mayers Haematoxylin 
1 g haematoxylin was dissolved in  
800 ml distilled H2O. 
50 g aluminium ammonium sulphate was added and dissolved. 
0.2 g sodium iodate, 
1 g citric acid and 
50 g chloral hydrate were added in the specified order, dissolving each reagent prior 
addition of the next compound.  The volume was made up to 1000 ml with distilled H2O 






1 g haematoxylin was dissolved in  














4 ml 30% aqueous ferric chloride (anhydrate), and 
1 ml concentrated HCl were added to 
95 ml distilled H2O.  Equal volumes of solutions a and b were mixed before use. 
 
Eosin 
150 ml of 1% Eosin was added to 
75 ml 1% Phloxine solution.  The solution was filtered through Whatmann filter paper 
no. 1 and stored at room temperature. 
 
Carbol Fuchsin 
10 ml 6% Basic fuchsin (in absolute alchohol) and 
90 ml 5% carbolic acid were mixed and passed through a Whatmann filter paper no. 1.  
The solution was stored at room temperature. 
 
Loeffers’ Methylene Blue 
1 ml 1% KOH, 
99 ml distilled H2O and 
3 ml 0.8% Methylene Blue (in absolute alcohol) were mixed and filtered through 
Whatmann filter paper no. 1 and the solution was stored at room temperature.   
   
 
Paraffin wax embedding 
Tissue samples were dehydrated using an automated tissue processor (LEICA TP1020, 
Wetzlar, Germany) and were embedded in wax (LEICAEG1140C, Wetzlar, Germany) in 
the following way: 
70% alcohol, 30 min, 
96% alcohol, 45 min (2x), 
100% alcohol, 45 min (4x), 
Xylol, 60 min (2x) 
Wax (55°C - 60°C), 45 min (2x) with vacuum 
 
Sections of 2 µm – 3 µm in size were cut using a microtome (Leica RM-2125RT or SM 
2000R, Heidelberger, Strasse) then floated onto glass slides and fixed overnight at 37°C.  
The wax was removed from tissue section by incubating at 60°C for 2 - 18 h.  Prior to 
staining, tissues were rehydrated in the following way: 
Xylol, 3 min, 
Xylol, 1 min (2x), 
Absolute alcohol, 1 min (2x) 
96% alcohol, 1 min (2x) 
70% alcohol, 1 min (2x), 
















Haematoxylin and Eosin staining protocol (H&E)  
Mice were euthanized by carbon dioxide inhalation at specific time points.  Rehydrated 
tissue was immersed for 8 min in Haematoxylin, rinsed with water then immersed in 1% 
acid alcohol.  Subsequently, tissues were rinsed in running water for 30 min then 
counterstained by soaking in 1% Eosin for 2 min, followed by a quick wash in water and 
dehydrated by 10 sec immersions in 70% alcohol, 96% alcohol and xylol, in that order.  
Sections were mounted using entellen (Merck, Germany). 
 
Ziehl-Neelson staining protocol (ZN) 
Rehydrated tissues were soaked in Carbol Fuschin solution, flamed and then allowed to 
cool for 5 min.  The flaming and cooling procedure was repeated followed by rinsing in 
water.  The slides were subsequently soaked in 1% acid alcohol for 30 sec and rinsed in 
water, followed by staining with 25% H2SO4 for 20 min and then rinsing under running 
water.  Tissues were then stained with Methylene Blue for 1 min then followed by a 
quick rinse with water and subsequently dehydrated by 10 sec immersions in 70% 
alcohol, 96% alcohol and xylol, in that order.  Sections were mounted using entellen 
(Merck, Germany). 
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